,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
335,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,2/55,0.0006615177095993661,0.0152149073207854,0,0,62.68238993710692,458.8961346318759,HDAC4;NRG1
336,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,2/84,0.0015350048968418,0.0176525563136815,0,0,40.45528455284553,262.1187578709559,HDAC4;NRG1
0,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),3/111,5.792034580725333e-05,0.0184765903125138,0,0,50.196969696969695,489.7438153664009,PRKN;HDAC4;NRG1
358,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),2/16,5.429523345740245e-05,0.0189367697709586,0,0,237.7619047619048,2335.077288749032,HDAC4;NRG1
359,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),2/17,6.15100567126949e-05,0.0189367697709586,0,0,221.9,2151.6111607602743,HDAC4;NRG1
360,GO_Biological_Process_2017b,central nervous system development (GO:0007417),4/333,6.621248171663877e-05,0.0189367697709586,0,0,23.899088145896656,229.97235901148497,PRKN;HDAC4;RBFOX1;NRG1
384,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),3/328,0.0013910728044298,0.0307145214917476,0,0,16.49874125874126,108.52344086108675,HDAC4;NRG1;LIFR
385,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),3/328,0.0013910728044298,0.0307145214917476,0,0,16.49874125874126,108.52344086108675,HDAC4;NRG1;LIFR
386,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),3/328,0.0013910728044298,0.0307145214917476,0,0,16.49874125874126,108.52344086108675,HDAC4;NRG1;LIFR
387,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),3/328,0.0013910728044298,0.0307145214917476,0,0,16.49874125874126,108.52344086108675,HDAC4;NRG1;LIFR
388,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),3/329,0.001403292775304,0.0307145214917476,0,0,16.44729503625209,108.04119263717648,HDAC4;NRG1;LIFR
389,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),3/329,0.001403292775304,0.0307145214917476,0,0,16.44729503625209,108.04119263717648,HDAC4;NRG1;LIFR
390,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),3/330,0.001415580611517,0.0307145214917476,0,0,16.396163469557965,107.56236583005573,HDAC4;NRG1;LIFR
391,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),3/330,0.001415580611517,0.0307145214917476,0,0,16.396163469557965,107.56236583005573,HDAC4;NRG1;LIFR
392,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),3/330,0.001415580611517,0.0307145214917476,0,0,16.396163469557965,107.56236583005573,HDAC4;NRG1;LIFR
393,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),3/330,0.001415580611517,0.0307145214917476,0,0,16.396163469557965,107.56236583005573,HDAC4;NRG1;LIFR
394,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),3/334,0.0014654135547714,0.0307145214917476,0,0,16.194726723427628,105.6805967523362,HDAC4;NRG1;LIFR
395,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),3/334,0.0014654135547714,0.0307145214917476,0,0,16.194726723427628,105.6805967523362,HDAC4;NRG1;LIFR
396,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),3/335,0.0014780429239045,0.0307145214917476,0,0,16.14512595837897,105.218373795418,HDAC4;NRG1;LIFR
397,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),3/335,0.0014780429239045,0.0307145214917476,0,0,16.14512595837897,105.218373795418,HDAC4;NRG1;LIFR
398,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),3/335,0.0014780429239045,0.0307145214917476,0,0,16.14512595837897,105.218373795418,HDAC4;NRG1;LIFR
383,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),3/328,0.0013910728044298,0.0307145214917476,0,0,16.49874125874126,108.52344086108675,HDAC4;NRG1;LIFR
382,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
380,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
399,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),3/337,0.0015035080450505,0.0307145214917476,0,0,16.046815459989112,104.30356562069318,HDAC4;NRG1;LIFR
371,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),3/270,0.000793213893224336,0.0307145214917476,0,0,20.141981613891726,143.80201896084694,HDAC4;RBFOX1;NRG1
370,GO_Biological_Process_2017b,neural tube development (GO:0021915),3/259,0.0007030223531100502,0.0307145214917476,0,0,21.01917613636364,152.60178035524086,HDAC4;RBFOX1;NRG1
369,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),3/255,0.0006719389651921211,0.0307145214917476,0,0,21.357142857142858,156.0212550789087,HDAC4;RBFOX1;NRG1
368,GO_Biological_Process_2017b,positive regulation of protein binding (GO:0032092),2/55,0.0006615177095993661,0.0307145214917476,0,0,62.68238993710692,458.8961346318759,PRKN;HDAC4
367,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),3/245,0.0005981286507964455,0.0307145214917476,0,0,22.250939143501128,165.13989944363593,HDAC4;RBFOX1;NRG1
366,GO_Biological_Process_2017b,nervous system development (GO:0007399),3/244,0.0005910491221295203,0.0307145214917476,0,0,22.34439834024896,166.09957483244798,HDAC4;RBFOX1;NRG1
365,GO_Biological_Process_2017b,ganglion development (GO:0061548),3/244,0.0005910491221295203,0.0307145214917476,0,0,22.34439834024896,166.09957483244798,HDAC4;RBFOX1;NRG1
364,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),3/244,0.0005910491221295203,0.0307145214917476,0,0,22.34439834024896,166.09957483244798,HDAC4;RBFOX1;NRG1
363,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),2/51,0.0005688783229383101,0.0307145214917476,0,0,67.81292517006803,506.6875974033785,PRKN;NRG1
362,GO_Biological_Process_2017b,negative regulation of protein autophosphorylation (GO:0031953),2/50,0.0005467878206419364,0.0307145214917476,0,0,69.22916666666667,520.0114050756229,PRKN;MOB1B
361,GO_Biological_Process_2017b,response to interleukin-1 (GO:0070555),2/48,0.0005038936977770158,0.0307145214917476,0,0,72.2463768115942,548.5772314174202,HDAC4;LIFR
374,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
375,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
376,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
377,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
378,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
379,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
381,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),3/327,0.0013789205507773,0.0307145214917476,0,0,16.550505050505052,109.00914508226614,HDAC4;NRG1;LIFR
372,GO_Biological_Process_2017b,neurogenesis (GO:0022008),3/272,0.0008103673564198415,0.0307145214917476,0,0,19.99019939168638,142.29069677903192,HDAC4;RBFOX1;NRG1
373,GO_Biological_Process_2017b,synapse assembly (GO:0007416),3/285,0.000927668237733678,0.0307145214917476,0,0,19.056092843326887,133.06557858693773,HDAC4;RBFOX1;NRG1
402,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),3/348,0.0016485332738654,0.031432034421701,0,0,15.526482213438737,99.49166888837016,HDAC4;NRG1;LIFR
400,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),3/345,0.0016081415533322,0.031432034421701,0,0,15.665071770334928,100.76833249077052,HDAC4;NRG1;LIFR
401,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),3/347,0.0016349989420206,0.031432034421701,0,0,15.572410147991544,99.9143450872614,HDAC4;NRG1;LIFR
403,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),2/89,0.0017209072173333,0.032098660705913,0,0,38.12068965517241,242.6345176901357,PRKN;NRG1
405,GO_Biological_Process_2017b,selective autophagy (GO:0061912),2/91,0.0017981323113668,0.0321416150656818,0,0,37.26029962546816,235.52260572132244,PRKN;ATG16L1
404,GO_Biological_Process_2017b,macroautophagy (GO:0016236),2/91,0.0017981323113668,0.0321416150656818,0,0,37.26029962546816,235.52260572132244,PRKN;ATG16L1
406,GO_Biological_Process_2017b,autophagosome organization (GO:1905037),2/93,0.0018769879803781,0.0328664425951931,0,0,36.43772893772893,228.75922962184185,PRKN;ATG16L1
1,GO_Biological_Process_2018,nervous system development (GO:0007399),4/455,0.00022075874198978652,0.0352110193473709,0,0,17.325942350332593,145.85740816335618,PRKN;HDAC4;RBFOX1;NRG1
2,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),2/40,0.00034955273047183893,0.0371691070068388,0,0,87.49122807017544,696.3300971664896,PRKN;NRG1
407,GO_Biological_Process_2017b,autophagosome maturation (GO:0097352),2/103,0.0022955833688117,0.0393922106088092,0,0,32.81353135313531,199.40022636888148,PRKN;ATG16L1
14,GO_Biological_Process_2018,regulation of dopamine metabolic process (GO:0042053),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
19,GO_Biological_Process_2018,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
20,GO_Biological_Process_2018,regulation of protein targeting (GO:1903533),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
18,GO_Biological_Process_2018,regulation of glucokinase activity (GO:0033131),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
17,GO_Biological_Process_2018,response to manganese ion (GO:0010042),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
16,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PTPRD
15,GO_Biological_Process_2018,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
13,GO_Biological_Process_2018,negative regulation of glycolytic process (GO:0045820),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,HDAC4
8,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),2/128,0.0035166775082517,0.0408666141359778,0,0,26.26984126984127,148.43087181068822,PRKN;NRG1
11,GO_Biological_Process_2018,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
10,GO_Biological_Process_2018,negative regulation of coenzyme metabolic process (GO:0051198),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,HDAC4
9,GO_Biological_Process_2018,response to cytokine (GO:0034097),2/138,0.0040736538548348,0.0408666141359778,0,0,24.32598039215686,133.8710984624244,HDAC4;LIFR
21,GO_Biological_Process_2018,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,PRKN
7,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),2/120,0.0030990937422035,0.0408666141359778,0,0,28.062146892655367,162.1050760117549,PTPRD;LIFR
6,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),3/424,0.0028936952231334,0.0408666141359778,0,0,12.67436838695746,74.0844838728883,HDAC4;NRG1;LIFR
5,GO_Biological_Process_2018,macroautophagy (GO:0016236),2/110,0.0026125248413519,0.0408666141359778,0,0,30.675925925925927,182.44317223306,PRKN;ATG16L1
4,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),2/88,0.0016829074036537,0.0408666141359778,0,0,38.565891472868216,246.32931092995028,PRKN;NRG1
3,GO_Biological_Process_2018,negative regulation of phosphorylation (GO:0042326),2/75,0.0012263294238969,0.0408666141359778,0,0,45.4634703196347,304.774819858399,PRKN;HDAC4
12,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0041931197986946,0.0408666141359778,0,0,307.4,1682.8029678019434,NRG1
22,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,NRG1
45,GO_Biological_Process_2018,positive regulation of cytoplasmic transport (GO:1903651),1/10,0.0069794736802133,0.0408666141359778,0,0,170.74358974358975,847.7046615380154,PRKN
24,GO_Biological_Process_2018,nucleic acid transport (GO:0050657),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,RBFOX1
44,GO_Biological_Process_2018,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,0.0069794736802133,0.0408666141359778,0,0,170.74358974358975,847.7046615380154,PRKN
43,GO_Biological_Process_2018,positive regulation of protein sumoylation (GO:0033235),1/9,0.0062835642580931,0.0408666141359778,0,0,192.09615384615384,973.8925197668603,HDAC4
42,GO_Biological_Process_2018,cellular response to dopamine (GO:1903351),1/9,0.0062835642580931,0.0408666141359778,0,0,192.09615384615384,973.8925197668603,PRKN
41,GO_Biological_Process_2018,potassium ion export (GO:0071435),1/9,0.0062835642580931,0.0408666141359778,0,0,192.09615384615384,973.8925197668603,KCND3
40,GO_Biological_Process_2018,response to dopamine (GO:1903350),1/9,0.0062835642580931,0.0408666141359778,0,0,192.09615384615384,973.8925197668603,PRKN
39,GO_Biological_Process_2018,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.0062835642580931,0.0408666141359778,0,0,192.09615384615384,973.8925197668603,PRKN
37,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,NRG1
36,GO_Biological_Process_2018,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,KCND3
23,GO_Biological_Process_2018,peptidyl-lysine deacetylation (GO:0034983),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,HDAC4
35,GO_Biological_Process_2018,regulation of response to oxidative stress (GO:1902882),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,PRKN
33,GO_Biological_Process_2018,protein K6-linked ubiquitination (GO:0085020),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,PRKN
32,GO_Biological_Process_2018,histone H4 deacetylation (GO:0070933),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,HDAC4
31,GO_Biological_Process_2018,regulation of lipid transport (GO:0032368),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,PRKN
30,GO_Biological_Process_2018,cardiac muscle hypertrophy (GO:0003300),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,HDAC4
29,GO_Biological_Process_2018,regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,PRKN
28,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),3/519,0.005108669066168,0.0408666141359778,0,0,10.290697674418604,54.30212189985708,HDAC4;NRG1;LIFR
26,GO_Biological_Process_2018,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,PRKN
25,GO_Biological_Process_2018,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,PRKN
34,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,NRG1
27,GO_Biological_Process_2018,regulation of mitochondrial fusion (GO:0010635),1/7,0.0048903875335643,0.0408666141359778,0,0,256.15384615384613,1362.8623704331803,PRKN
38,GO_Biological_Process_2018,negative regulation of exocytosis (GO:0045920),1/8,0.0055872022837974,0.0408666141359778,0,0,219.5494505494505,1138.8637280375192,PRKN
55,GO_Biological_Process_2018,viral RNA genome replication (GO:0039694),1/12,0.0083699358209422,0.0408666141359778,0,0,139.6853146853147,668.1300945358273,ATG16L1
76,GO_Biological_Process_2018,presynapse assembly (GO:0099054),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,PTPRD
75,GO_Biological_Process_2018,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,PRKN
74,GO_Biological_Process_2018,catecholamine metabolic process (GO:0006584),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,PRKN
73,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,NRG1
72,GO_Biological_Process_2018,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,KCND3
71,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,NRG1
70,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,NRG1
69,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,NRG1
68,GO_Biological_Process_2018,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,PRKN
67,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,NRG1
66,GO_Biological_Process_2018,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,PRKN
65,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,NRG1
64,GO_Biological_Process_2018,positive regulation of mitochondrial fission (GO:0090141),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,PRKN
63,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.009758590659951,0.0408666141359778,0,0,118.18343195266272,547.1428779573204,PRKN
62,GO_Biological_Process_2018,membrane repolarization (GO:0086009),1/13,0.0090644890278939,0.0408666141359778,0,0,128.03846153846155,602.2149225510485,KCND3
61,GO_Biological_Process_2018,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,0.0090644890278939,0.0408666141359778,0,0,128.03846153846155,602.2149225510485,PRKN
60,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.0090644890278939,0.0408666141359778,0,0,128.03846153846155,602.2149225510485,NRG1
53,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),3/618,0.0082855733978078,0.0408666141359778,0,0,8.590243902439024,41.17509571216885,PRKN;HDAC4;NRG1
59,GO_Biological_Process_2018,regulation of synaptic vesicle transport (GO:1902803),1/13,0.0090644890278939,0.0408666141359778,0,0,128.03846153846155,602.2149225510485,PRKN
58,GO_Biological_Process_2018,modulation by virus of host process (GO:0019054),1/13,0.0090644890278939,0.0408666141359778,0,0,128.03846153846155,602.2149225510485,PRKN
57,GO_Biological_Process_2018,histone H3 deacetylation (GO:0070932),1/12,0.0083699358209422,0.0408666141359778,0,0,139.6853146853147,668.1300945358273,HDAC4
77,GO_Biological_Process_2018,negative regulation of insulin secretion (GO:0046676),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,PRKN
56,GO_Biological_Process_2018,negative regulation of ATP metabolic process (GO:1903579),1/12,0.0083699358209422,0.0408666141359778,0,0,139.6853146853147,668.1300945358273,HDAC4
78,GO_Biological_Process_2018,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.0104522409709381,0.0408666141359778,0,0,109.73626373626374,500.5003914455875,PRKN
80,GO_Biological_Process_2018,regulation of exosomal secretion (GO:1903541),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,PRKN
47,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.0069794736802133,0.0408666141359778,0,0,170.74358974358975,847.7046615380154,PTPRD
46,GO_Biological_Process_2018,negative regulation by host of viral process (GO:0044793),1/10,0.0069794736802133,0.0408666141359778,0,0,170.74358974358975,847.7046615380154,PRKN
48,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.0076749307875411,0.0408666141359778,0,0,153.66153846153847,748.3003458854362,PTPRD
49,GO_Biological_Process_2018,modulation by host of viral genome replication (GO:0044827),1/11,0.0076749307875411,0.0408666141359778,0,0,153.66153846153847,748.3003458854362,PRKN
50,GO_Biological_Process_2018,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0076749307875411,0.0408666141359778,0,0,153.66153846153847,748.3003458854362,KCND3
51,GO_Biological_Process_2018,negative regulation of myotube differentiation (GO:0010832),1/11,0.0076749307875411,0.0408666141359778,0,0,153.66153846153847,748.3003458854362,HDAC4
52,GO_Biological_Process_2018,membrane repolarization during action potential (GO:0086011),1/11,0.0076749307875411,0.0408666141359778,0,0,153.66153846153847,748.3003458854362,KCND3
79,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,NRG1
54,GO_Biological_Process_2018,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.0083699358209422,0.0408666141359778,0,0,139.6853146853147,668.1300945358273,PRKN
86,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,NRG1
85,GO_Biological_Process_2018,negative regulation of peptide hormone secretion (GO:0090278),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,PRKN
84,GO_Biological_Process_2018,regulation of dopamine secretion (GO:0014059),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,PRKN
83,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,PTPRD
82,GO_Biological_Process_2018,negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,HDAC4
81,GO_Biological_Process_2018,protein deacylation (GO:0035601),1/16,0.011145440218903,0.0408666141359778,0,0,102.4153846153846,460.53380130419424,HDAC4
90,GO_Biological_Process_2018,negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/17,0.0118381886593292,0.0410476324165874,0,0,96.0096153846154,425.9394239533148,HDAC4
88,GO_Biological_Process_2018,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.0118381886593292,0.0410476324165874,0,0,96.0096153846154,425.9394239533148,PRKN
87,GO_Biological_Process_2018,regulation of protein sumoylation (GO:0033233),1/17,0.0118381886593292,0.0410476324165874,0,0,96.0096153846154,425.9394239533148,HDAC4
89,GO_Biological_Process_2018,regulation of protein localization to membrane (GO:1905475),1/17,0.0118381886593292,0.0410476324165874,0,0,96.0096153846154,425.9394239533148,PRKN
91,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0118381886593292,0.0410476324165874,0,0,96.0096153846154,425.9394239533148,NRG1
92,GO_Biological_Process_2018,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.0125304865571366,0.0425236724651766,0,0,90.3574660633484,395.7287161899813,PRKN
93,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.0125304865571366,0.0425236724651766,0,0,90.3574660633484,395.7287161899813,NRG1
97,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),3/740,0.0135325224641944,0.0427013311399683,0,0,7.1231034908104105,30.648288329216413,HDAC4;NRG1;LIFR
98,GO_Biological_Process_2018,regulation of response to cytokine stimulus (GO:0060759),1/20,0.01391373176082,0.0427013311399683,0,0,80.83805668016194,345.57291333057793,LIFR
94,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.013222334171232,0.0427013311399683,0,0,85.33333333333333,369.13902050225767,NRG1
95,GO_Biological_Process_2018,regulation of myotube differentiation (GO:0010830),1/19,0.013222334171232,0.0427013311399683,0,0,85.33333333333333,369.13902050225767,HDAC4
96,GO_Biological_Process_2018,regulation of mitochondrial fission (GO:0090140),1/19,0.013222334171232,0.0427013311399683,0,0,85.33333333333333,369.13902050225767,PRKN
103,GO_Biological_Process_2018,regulation of protein phosphorylation (GO:0001932),2/261,0.013921437111463,0.0427013311399683,0,0,12.694337194337194,54.25972776169732,PRKN;MOB1B
102,GO_Biological_Process_2018,dopamine metabolic process (GO:0042417),1/20,0.01391373176082,0.0427013311399683,0,0,80.83805668016194,345.57291333057793,PRKN
101,GO_Biological_Process_2018,regulation of transport (GO:0051049),1/20,0.01391373176082,0.0427013311399683,0,0,80.83805668016194,345.57291333057793,PRKN
100,GO_Biological_Process_2018,negative regulation of actin filament bundle assembly (GO:0032232),1/20,0.01391373176082,0.0427013311399683,0,0,80.83805668016194,345.57291333057793,PRKN
99,GO_Biological_Process_2018,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.01391373176082,0.0427013311399683,0,0,80.83805668016194,345.57291333057793,PRKN
488,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,NRG1
465,GO_Biological_Process_2017b,leukemia inhibitory factor signaling pathway (GO:0048861),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,LIFR
464,GO_Biological_Process_2017b,negative regulation of nitric oxide metabolic process (GO:1904406),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,PRKN
463,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,NRG1
462,GO_Biological_Process_2017b,regulation of peptidyl-tyrosine autophosphorylation (GO:1900084),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,MOB1B
461,GO_Biological_Process_2017b,negative regulation of lipid transport (GO:0032369),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,PRKN
460,GO_Biological_Process_2017b,dsRNA transport (GO:0033227),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,RBFOX1
457,GO_Biological_Process_2017b,potassium ion export from cell (GO:0098668),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,KCND3
458,GO_Biological_Process_2017b,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,PRKN
466,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,NRG1
456,GO_Biological_Process_2017b,positive regulation of protein sumoylation (GO:0033235),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,HDAC4
455,GO_Biological_Process_2017b,cardiac muscle cell membrane repolarization (GO:0099622),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,KCND3
454,GO_Biological_Process_2017b,potassium ion export (GO:0071435),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,KCND3
453,GO_Biological_Process_2017b,positive regulation of synaptic vesicle transport (GO:1902805),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,PRKN
452,GO_Biological_Process_2017b,axonal transport of messenger ribonucleoprotein complex (GO:0099088),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,RBFOX1
451,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,PRKN
459,GO_Biological_Process_2017b,membrane repolarization during Purkinje myocyte action potential (GO:0086051),1/9,0.0062835642580931,0.0430756203054901,0,0,192.09615384615384,973.8925197668603,KCND3
467,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,NRG1
471,GO_Biological_Process_2017b,negative regulation of skeletal muscle fiber differentiation (GO:1902810),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
469,GO_Biological_Process_2017b,positive regulation of SUMO transferase activity (GO:1903755),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,HDAC4
487,GO_Biological_Process_2017b,negative stranded viral RNA replication (GO:0039689),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,ATG16L1
486,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,NRG1
485,GO_Biological_Process_2017b,regulation of heparan sulfate proteoglycan binding (GO:1905858),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
484,GO_Biological_Process_2017b,regulation of C-C chemokine binding (GO:2001263),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
483,GO_Biological_Process_2017b,tubulin deacetylation (GO:0090042),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
482,GO_Biological_Process_2017b,regulation of collagen binding (GO:0033341),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
481,GO_Biological_Process_2017b,regulation of actin binding (GO:1904616),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
480,GO_Biological_Process_2017b,Hsp90 deacetylation (GO:0070846),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
468,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.0069794736802133,0.0430756203054901,0,0,170.74358974358975,847.7046615380154,NRG1
479,GO_Biological_Process_2017b,negative regulation of superoxide anion generation (GO:0032929),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,PRKN
477,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,NRG1
476,GO_Biological_Process_2017b,regulation of glucokinase activity (GO:0033131),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,PRKN
475,GO_Biological_Process_2017b,protein deacetylation (GO:0006476),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
474,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,NRG1
473,GO_Biological_Process_2017b,regulation of apolipoprotein binding (GO:2000656),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
472,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,NRG1
450,GO_Biological_Process_2017b,histone H4-K16 deacetylation (GO:1990678),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,HDAC4
470,GO_Biological_Process_2017b,regulation of Ras GTPase binding (GO:1904475),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
478,GO_Biological_Process_2017b,regulation of receptor binding (GO:1900120),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
449,GO_Biological_Process_2017b,cardiac muscle hypertrophy in response to stress (GO:0014898),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,HDAC4
422,GO_Biological_Process_2017b,mitochondrial unfolded protein response (GO:0034514),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
447,GO_Biological_Process_2017b,histone H4-K12 deacetylation (GO:1990679),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,HDAC4
424,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
423,GO_Biological_Process_2017b,regulation of protein import into mitochondrial outer membrane (GO:1903636),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
421,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
420,GO_Biological_Process_2017b,negative regulation of actin filament bundle assembly (GO:0032232),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
419,GO_Biological_Process_2017b,regulation of phospholipid transport (GO:2001138),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
418,GO_Biological_Process_2017b,cellular response to manganese ion (GO:0071287),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
417,GO_Biological_Process_2017b,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
416,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,NRG1
415,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0041931197986946,0.0430756203054901,0,0,307.4,1682.8029678019434,PRKN
414,GO_Biological_Process_2017b,autophagosome-lysosome fusion (GO:0061909),2/138,0.0040736538548348,0.0430756203054901,0,0,24.32598039215686,133.8710984624244,PRKN;ATG16L1
413,GO_Biological_Process_2017b,autophagosome-endosome fusion (GO:0061910),2/138,0.0040736538548348,0.0430756203054901,0,0,24.32598039215686,133.8710984624244,PRKN;ATG16L1
412,GO_Biological_Process_2017b,amphisome-lysosome fusion (GO:0061911),2/138,0.0040736538548348,0.0430756203054901,0,0,24.32598039215686,133.8710984624244,PRKN;ATG16L1
411,GO_Biological_Process_2017b,"negative regulation of gene expression, epigenetic (GO:0045814)",2/133,0.0037903316158867,0.0430756203054901,0,0,25.260814249363868,140.83666229810896,PRKN;HDAC4
410,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),3/442,0.0032546649800301,0.0430756203054901,0,0,12.143507972665148,69.55395692628468,HDAC4;NRG1;LIFR
409,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),3/419,0.0027980839421953,0.0430756203054901,0,0,12.829982517482517,75.42516298626586,HDAC4;NRG1;LIFR
408,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),2/113,0.0027543382287582,0.0430756203054901,0,0,29.84234234234234,175.90801680556538,PRKN;NRG1
489,GO_Biological_Process_2017b,regulation of UDP-glucose catabolic process (GO:0010904),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,PRKN
425,GO_Biological_Process_2017b,negative regulation of exosomal secretion (GO:1903542),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
426,GO_Biological_Process_2017b,dendritic transport of ribonucleoprotein complex (GO:0098961),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,RBFOX1
427,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
428,GO_Biological_Process_2017b,regulation of fatty acid transport (GO:2000191),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
446,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,NRG1
445,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,NRG1
444,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,NRG1
443,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),2/159,0.005367810392313,0.0430756203054901,0,0,21.049893842887474,110.03485107878144,PRKN;PTPRD
442,GO_Biological_Process_2017b,negative regulation of primary amine oxidase activity (GO:1902283),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
441,GO_Biological_Process_2017b,dopamine metabolic process (GO:0042417),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
440,GO_Biological_Process_2017b,RNA transport (GO:0050658),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,RBFOX1
439,GO_Biological_Process_2017b,regulation of removal of superoxide radicals (GO:2000121),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
448,GO_Biological_Process_2017b,rRNA transport (GO:0051029),1/8,0.0055872022837974,0.0430756203054901,0,0,219.5494505494505,1138.8637280375192,RBFOX1
438,GO_Biological_Process_2017b,negative regulation of mitochondrial fusion (GO:0010637),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
436,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
435,GO_Biological_Process_2017b,tRNA transport (GO:0051031),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,RBFOX1
434,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
433,GO_Biological_Process_2017b,positive regulation of mitochondrial fusion (GO:0010636),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,PRKN
432,GO_Biological_Process_2017b,snRNA transport (GO:0051030),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,RBFOX1
431,GO_Biological_Process_2017b,miRNA transport (GO:1990428),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,RBFOX1
430,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
429,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
437,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0048903875335643,0.0430756203054901,0,0,256.15384615384613,1362.8623704331803,NRG1
490,GO_Biological_Process_2017b,regulation of glucose metabolic process (GO:0010906),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,PRKN
520,GO_Biological_Process_2017b,regulation of cristae formation (GO:1903850),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
492,GO_Biological_Process_2017b,regulation of microtubule binding (GO:1904526),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,HDAC4
557,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
556,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
555,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
554,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
553,GO_Biological_Process_2017b,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
552,GO_Biological_Process_2017b,positive regulation of G-quadruplex DNA binding (GO:1905495),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
551,GO_Biological_Process_2017b,peptidyl-lysine deacetylation (GO:0034983),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,HDAC4
550,GO_Biological_Process_2017b,establishment of B cell polarity (GO:0001769),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,HDAC4
558,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
549,GO_Biological_Process_2017b,positive regulation of protein localization to plasma membrane (GO:1903078),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,PRKN
547,GO_Biological_Process_2017b,regulation of gluconeogenesis (GO:0006111),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,PRKN
546,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,NRG1
545,GO_Biological_Process_2017b,membrane repolarization during SA node cell action potential (GO:0086052),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,KCND3
544,GO_Biological_Process_2017b,B cell activation (GO:0042113),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,HDAC4
542,GO_Biological_Process_2017b,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,PRKN
541,GO_Biological_Process_2017b,regulation of superoxide metabolic process (GO:0090322),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
540,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,NRG1
539,GO_Biological_Process_2017b,regulation of histone ubiquitination (GO:0033182),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
548,GO_Biological_Process_2017b,protein catabolic process in the vacuole (GO:0007039),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,PRKN
538,GO_Biological_Process_2017b,regulation of nitric oxide metabolic process (GO:0080164),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
559,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
561,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
579,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
578,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
577,GO_Biological_Process_2017b,regulation of protein targeting to mitochondrion (GO:1903214),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
576,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
575,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
574,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
573,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
572,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
491,GO_Biological_Process_2017b,regulation of protein binding (GO:0043393),1/11,0.0076749307875411,0.0430756203054901,0,0,153.66153846153847,748.3003458854362,HDAC4
571,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
569,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
568,GO_Biological_Process_2017b,presynaptic membrane assembly (GO:0097105),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
567,GO_Biological_Process_2017b,dopamine biosynthetic process (GO:0042416),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
566,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
565,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PTPRD
564,GO_Biological_Process_2017b,free ubiquitin chain polymerization (GO:0010994),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
563,GO_Biological_Process_2017b,negative regulation of dopamine secretion (GO:0033602),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
562,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide metabolic process (GO:0010727),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
570,GO_Biological_Process_2017b,positive regulation of recombination hotspot binding (GO:1903643),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
537,GO_Biological_Process_2017b,regulation of dopamine secretion (GO:0014059),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
560,GO_Biological_Process_2017b,positive regulation of triplex DNA binding (GO:1905498),1/16,0.011145440218903,0.0430756203054901,0,0,102.4153846153846,460.53380130419424,PRKN
535,GO_Biological_Process_2017b,negative regulation of mitochondrion organization (GO:0010823),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
510,GO_Biological_Process_2017b,regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
509,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,NRG1
508,GO_Biological_Process_2017b,mRNA transport (GO:0051028),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,RBFOX1
507,GO_Biological_Process_2017b,regulation of synaptic vesicle transport (GO:1902803),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
506,GO_Biological_Process_2017b,regulation of glucose catabolic process to lactate via pyruvate (GO:1904023),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
505,GO_Biological_Process_2017b,histone H3-K9 deacetylation (GO:1990619),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,HDAC4
504,GO_Biological_Process_2017b,regulation of glycolytic fermentation to ethanol (GO:2001154),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
503,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,NRG1
502,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,NRG1
501,GO_Biological_Process_2017b,membrane repolarization during bundle of His cell action potential (GO:0086050),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,KCND3
500,GO_Biological_Process_2017b,histone H3-K4 deacetylation (GO:1990596),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,HDAC4
499,GO_Biological_Process_2017b,regulation of protein polyubiquitination (GO:1902914),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
498,GO_Biological_Process_2017b,regulation of protein monoubiquitination (GO:1902525),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
497,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
496,GO_Biological_Process_2017b,histone H3-K56 deacetylation (GO:0071572),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,HDAC4
495,GO_Biological_Process_2017b,regulation of glycogen metabolic process (GO:0070873),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
494,GO_Biological_Process_2017b,regulation of protein ubiquitination (GO:0031396),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,PRKN
493,GO_Biological_Process_2017b,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/12,0.0083699358209422,0.0430756203054901,0,0,139.6853146853147,668.1300945358273,KCND3
536,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,NRG1
511,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PTPRD
512,GO_Biological_Process_2017b,regulation of mitochondrial DNA metabolic process (GO:1901858),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
543,GO_Biological_Process_2017b,regulation of mitochondrion organization (GO:0010821),1/15,0.0104522409709381,0.0430756203054901,0,0,109.73626373626374,500.5003914455875,PRKN
514,GO_Biological_Process_2017b,histone catabolic process (GO:0036205),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
534,GO_Biological_Process_2017b,cellular response to dopamine (GO:1903351),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
513,GO_Biological_Process_2017b,protein denaturation (GO:0030164),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
533,GO_Biological_Process_2017b,negative regulation of removal of superoxide radicals (GO:1904832),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
532,GO_Biological_Process_2017b,dopamine catabolic process (GO:0042420),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
531,GO_Biological_Process_2017b,regulation of mitochondrial fusion (GO:0010635),1/14,0.009758590659951,0.0430756203054901,0,0,118.18343195266272,547.1428779573204,PRKN
530,GO_Biological_Process_2017b,membrane repolarization during AV node cell action potential (GO:0086049),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,KCND3
529,GO_Biological_Process_2017b,dosage compensation (GO:0007549),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,HDAC4
528,GO_Biological_Process_2017b,regulation of protein autoubiquitination (GO:1902498),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
526,GO_Biological_Process_2017b,regulation of release of cytochrome c from mitochondria (GO:0090199),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
527,GO_Biological_Process_2017b,positive regulation of ERAD pathway (GO:1904294),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
524,GO_Biological_Process_2017b,rhodopsin catabolic process (GO:0046155),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
523,GO_Biological_Process_2017b,PSII associated light-harvesting complex II catabolic process (GO:0010304),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
522,GO_Biological_Process_2017b,negative regulation of skeletal muscle fiber development (GO:0048744),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,HDAC4
521,GO_Biological_Process_2017b,negative regulation of myoblast fusion (GO:1901740),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,HDAC4
519,GO_Biological_Process_2017b,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
518,GO_Biological_Process_2017b,negative regulation of protein targeting to mitochondrion (GO:1903215),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
517,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process (GO:2000377),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
516,GO_Biological_Process_2017b,negative regulation of myotube differentiation (GO:0010832),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,HDAC4
515,GO_Biological_Process_2017b,prosthetic group catabolic process (GO:0051190),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,PRKN
525,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.0090644890278939,0.0430756203054901,0,0,128.03846153846155,602.2149225510485,NRG1
589,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PTPRD
592,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,NRG1
591,GO_Biological_Process_2017b,positive regulation of telomeric DNA binding (GO:1904744),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
590,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PTPRD
588,GO_Biological_Process_2017b,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
582,GO_Biological_Process_2017b,protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
586,GO_Biological_Process_2017b,regulation of hydrogen peroxide metabolic process (GO:0010310),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
585,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PTPRD
584,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,NRG1
583,GO_Biological_Process_2017b,B cell activation involved in immune response (GO:0002312),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,HDAC4
581,GO_Biological_Process_2017b,cellular zinc ion homeostasis (GO:0006882),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
580,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PTPRD
587,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.0118381886593292,0.0432219824242746,0,0,96.0096153846154,425.9394239533148,PRKN
104,GO_Biological_Process_2018,protein O-linked glycosylation via threonine (GO:0018243),1/21,0.0146046795939876,0.0435639442808789,0,0,76.79230769230769,324.5560291468294,GALNTL6
105,GO_Biological_Process_2018,mitochondrial fission (GO:0000266),1/21,0.0146046795939876,0.0435639442808789,0,0,76.79230769230769,324.5560291468294,PRKN
106,GO_Biological_Process_2018,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,PRKN
107,GO_Biological_Process_2018,regulation of catecholamine secretion (GO:0050433),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,PRKN
108,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,NRG1
109,GO_Biological_Process_2018,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,PRKN
110,GO_Biological_Process_2018,protein O-linked glycosylation via serine (GO:0018242),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,GALNTL6
111,GO_Biological_Process_2018,cellular response to unfolded protein (GO:0034620),1/22,0.0152951779293368,0.0435639442808789,0,0,73.13186813186813,305.7071272789262,PRKN
594,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072335),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
597,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PTPRD
593,GO_Biological_Process_2017b,positive regulation of glucose metabolic process (GO:0010907),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
595,GO_Biological_Process_2017b,regulation of mitochondrial fission (GO:0090140),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
602,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
596,GO_Biological_Process_2017b,regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
599,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PTPRD
600,GO_Biological_Process_2017b,maintenance of unfolded protein involved in ERAD pathway (GO:1904378),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
601,GO_Biological_Process_2017b,regulation of ubiquitin-protein transferase activity (GO:0051438),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
598,GO_Biological_Process_2017b,positive regulation of DNA replication origin binding (GO:1902597),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,PRKN
603,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.0125304865571366,0.043703892138306,0,0,90.3574660633484,395.7287161899813,NRG1
112,GO_Biological_Process_2018,membrane assembly (GO:0071709),1/23,0.015985227036696,0.0439593743509141,0,0,69.8041958041958,288.7164567086745,PTPRD
113,GO_Biological_Process_2018,cellular response to catecholamine stimulus (GO:0071870),1/23,0.015985227036696,0.0439593743509141,0,0,69.8041958041958,288.7164567086745,PRKN
114,GO_Biological_Process_2018,divalent inorganic cation homeostasis (GO:0072507),1/23,0.015985227036696,0.0439593743509141,0,0,69.8041958041958,288.7164567086745,PRKN
115,GO_Biological_Process_2018,cellular response to ammonium ion (GO:0071242),1/23,0.015985227036696,0.0439593743509141,0,0,69.8041958041958,288.7164567086745,PRKN
117,GO_Biological_Process_2018,negative regulation of cytoskeleton organization (GO:0051494),1/24,0.0166748271779813,0.043960908014678,0,0,66.76588628762542,273.3298608380045,PRKN
118,GO_Biological_Process_2018,negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.0166748271779813,0.043960908014678,0,0,66.76588628762542,273.3298608380045,PRKN
119,GO_Biological_Process_2018,regulation of actin filament bundle assembly (GO:0032231),1/24,0.0166748271779813,0.043960908014678,0,0,66.76588628762542,273.3298608380045,PRKN
120,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0166748271779813,0.043960908014678,0,0,66.76588628762542,273.3298608380045,NRG1
116,GO_Biological_Process_2018,transition metal ion homeostasis (GO:0055076),1/24,0.0166748271779813,0.043960908014678,0,0,66.76588628762542,273.3298608380045,PRKN
604,GO_Biological_Process_2017b,positive regulation of dopamine secretion (GO:0033603),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,PRKN
606,GO_Biological_Process_2017b,positive regulation of mitochondrion organization (GO:0010822),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,PRKN
605,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,PTPRD
609,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,PTPRD
608,GO_Biological_Process_2017b,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,KCND3
607,GO_Biological_Process_2017b,negative regulation of cohesin unloading (GO:1905338),1/19,0.013222334171232,0.0450188996782425,0,0,85.33333333333333,369.13902050225767,PRKN
122,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",3/813,0.0174150761785918,0.0451659292761852,0,0,6.456565656565656,26.151796215684044,PRKN;HDAC4;NRG1
121,GO_Biological_Process_2018,regulation of glucose metabolic process (GO:0010906),1/25,0.0173639786153884,0.0451659292761852,0,0,63.98076923076923,259.3369252570107,PRKN
611,GO_Biological_Process_2017b,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,PRKN
610,GO_Biological_Process_2017b,establishment of mitochondrion localization involved in mitochondrial fission (GO:0090146),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,PRKN
616,GO_Biological_Process_2017b,"positive regulation of gene expression, epigenetic (GO:0045815)",2/261,0.013921437111463,0.0461181198518737,0,0,12.694337194337194,54.25972776169732,PRKN;HDAC4
612,GO_Biological_Process_2017b,regulation of gene expression by genetic imprinting (GO:0006349),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,HDAC4
613,GO_Biological_Process_2017b,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,PRKN
614,GO_Biological_Process_2017b,mitochondrial nucleoid organization involved in mitochondrial fission (GO:0090145),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,PRKN
615,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.01391373176082,0.0461181198518737,0,0,80.83805668016194,345.57291333057793,PTPRD
123,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),1/26,0.0180526816175866,0.0464419793226624,0,0,61.418461538461536,246.562020931719,PTPRD
125,GO_Biological_Process_2018,cellular response to topologically incorrect protein (GO:0035967),1/27,0.0187409364492418,0.0474472914865727,0,0,59.05325443786983,234.8574522333829,PRKN
124,GO_Biological_Process_2018,regulation of autophagy of mitochondrion (GO:1903146),1/27,0.0187409364492418,0.0474472914865727,0,0,59.05325443786983,234.8574522333829,PRKN
618,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0146046795939876,0.0476456847590928,0,0,76.79230769230769,324.5560291468294,NRG1
617,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079),1/21,0.0146046795939876,0.0476456847590928,0,0,76.79230769230769,324.5560291468294,PRKN
620,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0146046795939876,0.0476456847590928,0,0,76.79230769230769,324.5560291468294,PTPRD
619,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0146046795939876,0.0476456847590928,0,0,76.79230769230769,324.5560291468294,NRG1
127,GO_Biological_Process_2018,protein K11-linked ubiquitination (GO:0070979),1/28,0.0194287433776428,0.0480447219958765,0,0,56.86324786324786,224.0981560428528,PRKN
128,GO_Biological_Process_2018,negative regulation of JNK cascade (GO:0046329),1/28,0.0194287433776428,0.0480447219958765,0,0,56.86324786324786,224.0981560428528,PRKN
126,GO_Biological_Process_2018,organelle fission (GO:0048285),1/28,0.0194287433776428,0.0480447219958765,0,0,56.86324786324786,224.0981560428528,PRKN
621,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),3/770,0.015059330215953,0.0489428232018474,0,0,6.833827189759393,28.673081903626045,PRKN;HDAC4;PTPRD
624,GO_Biological_Process_2017b,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/22,0.0152951779293368,0.0489673979976529,0,0,73.13186813186813,305.7071272789262,PRKN
625,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0152951779293368,0.0489673979976529,0,0,73.13186813186813,305.7071272789262,PTPRD
622,GO_Biological_Process_2017b,positive regulation of mitochondrial fission (GO:0090141),1/22,0.0152951779293368,0.0489673979976529,0,0,73.13186813186813,305.7071272789262,PRKN
623,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0152951779293368,0.0489673979976529,0,0,73.13186813186813,305.7071272789262,NRG1
129,GO_Biological_Process_2018,cardiac muscle cell action potential (GO:0086001),1/29,0.020116102664845,0.0493618211545044,0,0,54.82967032967033,214.17755847607225,KCND3
132,GO_Biological_Process_2018,negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.02080301457834,0.0498959522593267,0,0,52.93633952254642,205.00430545239047,PRKN
131,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.02080301457834,0.0498959522593267,0,0,52.93633952254642,205.00430545239047,NRG1
130,GO_Biological_Process_2018,hippo signaling (GO:0035329),1/30,0.02080301457834,0.0498959522593267,0,0,52.93633952254642,205.00430545239047,MOB1B
631,GO_Biological_Process_2017b,regulation of protein autophosphorylation (GO:0031952),1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,MOB1B
630,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,PTPRD
629,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,PTPRD
628,GO_Biological_Process_2017b,membrane repolarization during action potential (GO:0086011),1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,KCND3
627,GO_Biological_Process_2017b,cohesin loading (GO:0071921),1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,PRKN
626,GO_Biological_Process_2017b,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/23,0.015985227036696,0.0500559299178292,0,0,69.8041958041958,288.7164567086745,KCND3
135,GO_Biological_Process_2018,zinc ion homeostasis (GO:0055069),1/31,0.0214894793855565,0.0504054700293569,0,0,51.16923076923077,196.4996601316088,PRKN
133,GO_Biological_Process_2018,protein destabilization (GO:0031648),1/31,0.0214894793855565,0.0504054700293569,0,0,51.16923076923077,196.4996601316088,PRKN
134,GO_Biological_Process_2018,regulation of protein autophosphorylation (GO:0031952),1/31,0.0214894793855565,0.0504054700293569,0,0,51.16923076923077,196.4996601316088,MOB1B
632,GO_Biological_Process_2017b,positive regulation of cohesin loading (GO:1905309),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,PRKN
633,GO_Biological_Process_2017b,positive regulation of DNA binding (GO:0043388),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,PRKN
634,GO_Biological_Process_2017b,negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,PRKN
635,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,NRG1
636,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,PRKN
637,GO_Biological_Process_2017b,mitochondrial membrane fission (GO:0090149),1/24,0.0166748271779813,0.0510964347096713,0,0,66.76588628762542,273.3298608380045,PRKN
137,GO_Biological_Process_2018,protein deacetylation (GO:0006476),1/32,0.0221754973519546,0.0512607511251704,0,0,49.516129032258064,188.59541419671356,HDAC4
136,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),1/32,0.0221754973519546,0.0512607511251704,0,0,49.516129032258064,188.59541419671356,PTPRD
140,GO_Biological_Process_2018,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/33,0.022861068741375,0.0517211413368697,0,0,47.96634615384615,181.23219876999116,PRKN
139,GO_Biological_Process_2018,negative regulation of mitochondrion organization (GO:0010823),1/33,0.022861068741375,0.0517211413368697,0,0,47.96634615384615,181.23219876999116,PRKN
138,GO_Biological_Process_2018,oligosaccharide biosynthetic process (GO:0009312),1/33,0.022861068741375,0.0517211413368697,0,0,47.96634615384615,181.23219876999116,GALNTL6
144,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.0235461938251205,0.0518016264152651,0,0,46.51048951048951,174.35810878919273,NRG1
142,GO_Biological_Process_2018,positive regulation of DNA binding (GO:0043388),1/34,0.0235461938251205,0.0518016264152651,0,0,46.51048951048951,174.35810878919273,PRKN
143,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.0235461938251205,0.0518016264152651,0,0,46.51048951048951,174.35810878919273,NRG1
141,GO_Biological_Process_2018,negative regulation of cellular metabolic process (GO:0031324),1/34,0.0235461938251205,0.0518016264152651,0,0,46.51048951048951,174.35810878919273,PRKN
146,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0242308728650598,0.0522273543510411,0,0,45.14027149321267,167.92757529985917,NRG1
145,GO_Biological_Process_2018,regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.0242308728650598,0.0522273543510411,0,0,45.14027149321267,167.92757529985917,KCND3
147,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),1/35,0.0242308728650598,0.0522273543510411,0,0,45.14027149321267,167.92757529985917,PTPRD
647,GO_Biological_Process_2017b,positive regulation of mitophagy (GO:1901526),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,PRKN
639,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),1/25,0.0173639786153884,0.052505765518269,0,0,63.98076923076923,259.3369252570107,PRKN
640,GO_Biological_Process_2017b,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/25,0.0173639786153884,0.052505765518269,0,0,63.98076923076923,259.3369252570107,PRKN
641,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
642,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,PRKN
643,GO_Biological_Process_2017b,RNA import into nucleus (GO:0006404),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,RBFOX1
644,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,PRKN
645,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
646,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
648,GO_Biological_Process_2017b,histone deacetylation at centromere (GO:0031059),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,HDAC4
638,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0173639786153884,0.052505765518269,0,0,63.98076923076923,259.3369252570107,PTPRD
649,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
650,GO_Biological_Process_2017b,hippo signaling (GO:0035329),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,MOB1B
651,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
652,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0180526816175866,0.052505765518269,0,0,61.418461538461536,246.562020931719,NRG1
150,GO_Biological_Process_2018,carbohydrate biosynthetic process (GO:0016051),1/36,0.0249151061269709,0.0526352242020113,0,0,43.848351648351645,161.9004351330391,GALNTL6
149,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0249151061269709,0.0526352242020113,0,0,43.848351648351645,161.9004351330391,NRG1
148,GO_Biological_Process_2018,histone deacetylation (GO:0016575),1/36,0.0249151061269709,0.0526352242020113,0,0,43.848351648351645,161.9004351330391,HDAC4
657,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,PRKN
658,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,NRG1
659,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,NRG1
653,GO_Biological_Process_2017b,micromitophagy (GO:0000424),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,PRKN
654,GO_Biological_Process_2017b,protein destabilization (GO:0031648),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,PRKN
655,GO_Biological_Process_2017b,positive regulation of proteasomal protein catabolic process (GO:1901800),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,PRKN
656,GO_Biological_Process_2017b,autophagy of mitochondrion (GO:0000422),1/27,0.0187409364492418,0.0532441174617534,0,0,59.05325443786983,234.8574522333829,PRKN
151,GO_Biological_Process_2018,protein K63-linked ubiquitination (GO:0070534),1/37,0.025598893875467,0.0533728571651895,0,0,42.62820512820513,156.2411590204543,PRKN
152,GO_Biological_Process_2018,protein monoubiquitination (GO:0006513),1/37,0.025598893875467,0.0533728571651895,0,0,42.62820512820513,156.2411590204543,PRKN
676,GO_Biological_Process_2017b,response to interleukin-32 (GO:0097395),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
677,GO_Biological_Process_2017b,response to interleukin-3 (GO:0036015),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
678,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway (GO:0060828),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,PRKN
679,GO_Biological_Process_2017b,response to interleukin-7 (GO:0098760),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
680,GO_Biological_Process_2017b,response to interleukin-17 (GO:0097396),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
683,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,PTPRD
682,GO_Biological_Process_2017b,response to interleukin-13 (GO:0035962),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
675,GO_Biological_Process_2017b,response to macrophage colony-stimulating factor (GO:0036005),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
684,GO_Biological_Process_2017b,response to cytokine (GO:0034097),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
685,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,PRKN
686,GO_Biological_Process_2017b,response to stem cell factor (GO:0036215),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
681,GO_Biological_Process_2017b,response to chemokine (GO:1990868),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
674,GO_Biological_Process_2017b,response to granulocyte colony-stimulating factor (GO:1990638),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
671,GO_Biological_Process_2017b,response to interleukin-21 (GO:0098756),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
672,GO_Biological_Process_2017b,response to interleukin-18 (GO:0070673),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
687,GO_Biological_Process_2017b,response to interleukin-11 (GO:0071105),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
670,GO_Biological_Process_2017b,response to erythropoietin (GO:0036017),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
669,GO_Biological_Process_2017b,response to granulocyte macrophage colony-stimulating factor (GO:0097012),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
668,GO_Biological_Process_2017b,response to interleukin-8 (GO:0098758),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
667,GO_Biological_Process_2017b,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/29,0.020116102664845,0.0539244305384161,0,0,54.82967032967033,214.17755847607225,PRKN
665,GO_Biological_Process_2017b,negative regulation of stress fiber assembly (GO:0051497),1/29,0.020116102664845,0.0539244305384161,0,0,54.82967032967033,214.17755847607225,PRKN
664,GO_Biological_Process_2017b,histone H4 deacetylation (GO:0070933),1/29,0.020116102664845,0.0539244305384161,0,0,54.82967032967033,214.17755847607225,HDAC4
663,GO_Biological_Process_2017b,"retrograde protein transport, ER to cytosol (GO:0030970)",1/28,0.0194287433776428,0.0539244305384161,0,0,56.86324786324786,224.0981560428528,PRKN
662,GO_Biological_Process_2017b,mitophagy by induced vacuole formation (GO:0035695),1/28,0.0194287433776428,0.0539244305384161,0,0,56.86324786324786,224.0981560428528,PRKN
661,GO_Biological_Process_2017b,negative regulation of glycolytic process (GO:0045820),1/28,0.0194287433776428,0.0539244305384161,0,0,56.86324786324786,224.0981560428528,HDAC4
660,GO_Biological_Process_2017b,mitophagy (GO:0000423),1/28,0.0194287433776428,0.0539244305384161,0,0,56.86324786324786,224.0981560428528,PRKN
673,GO_Biological_Process_2017b,response to leukemia inhibitory factor (GO:1990823),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,LIFR
688,GO_Biological_Process_2017b,ER-associated misfolded protein catabolic process (GO:0071712),1/30,0.02080301457834,0.0539244305384161,0,0,52.93633952254642,205.00430545239047,PRKN
666,GO_Biological_Process_2017b,positive regulation of dendrite morphogenesis (GO:0050775),1/29,0.020116102664845,0.0539244305384161,0,0,54.82967032967033,214.17755847607225,PTPRD
696,GO_Biological_Process_2017b,response to interleukin-2 (GO:0070669),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
695,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,NRG1
694,GO_Biological_Process_2017b,mitochondrial DNA inheritance (GO:0033955),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,PRKN
693,GO_Biological_Process_2017b,response to interleukin-4 (GO:0070670),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
692,GO_Biological_Process_2017b,response to type III interferon (GO:0034342),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
691,GO_Biological_Process_2017b,response to interleukin-15 (GO:0070672),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
690,GO_Biological_Process_2017b,response to interleukin-9 (GO:0071104),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
689,GO_Biological_Process_2017b,response to interleukin-12 (GO:0070671),1/31,0.0214894793855565,0.0543893018076918,0,0,51.16923076923077,196.4996601316088,LIFR
153,GO_Biological_Process_2018,mitochondrion disassembly (GO:0061726),1/38,0.0262822363843274,0.0544417753675353,0,0,41.47401247401248,150.91820759135345,PRKN
154,GO_Biological_Process_2018,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/39,0.0269651339122192,0.0547800010334984,0,0,40.38056680161943,145.90349135778567,RBFOX1
155,GO_Biological_Process_2018,regulation of proteasomal protein catabolic process (GO:0061136),1/39,0.0269651339122192,0.0547800010334984,0,0,40.38056680161943,145.90349135778567,PRKN
156,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),1/39,0.0269651339122192,0.0547800010334984,0,0,40.38056680161943,145.90349135778567,NRG1
158,GO_Biological_Process_2018,negative regulation of catabolic process (GO:0009895),1/40,0.0276475867285054,0.0547800010334984,0,0,39.34319526627219,141.17191556098328,HDAC4
159,GO_Biological_Process_2018,autophagy of mitochondrion (GO:0000422),1/40,0.0276475867285054,0.0547800010334984,0,0,39.34319526627219,141.17191556098328,PRKN
160,GO_Biological_Process_2018,regulation of intracellular transport (GO:0032386),1/40,0.0276475867285054,0.0547800010334984,0,0,39.34319526627219,141.17191556098328,PRKN
157,GO_Biological_Process_2018,regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.0276475867285054,0.0547800010334984,0,0,39.34319526627219,141.17191556098328,PRKN
698,GO_Biological_Process_2017b,histone H3 deacetylation (GO:0070932),1/32,0.0221754973519546,0.0554710691777756,0,0,49.516129032258064,188.59541419671356,HDAC4
699,GO_Biological_Process_2017b,positive regulation of proteasome-activating ATPase activity (GO:1902887),1/32,0.0221754973519546,0.0554710691777756,0,0,49.516129032258064,188.59541419671356,PRKN
697,GO_Biological_Process_2017b,response to interleukin-6 (GO:0070741),1/32,0.0221754973519546,0.0554710691777756,0,0,49.516129032258064,188.59541419671356,LIFR
700,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0221754973519546,0.0554710691777756,0,0,49.516129032258064,188.59541419671356,NRG1
161,GO_Biological_Process_2018,regulation of cellular metabolic process (GO:0031323),1/41,0.0283295950973344,0.0557848199756154,0,0,38.35769230769231,136.70099489654157,PRKN
701,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",3/895,0.0224618940030452,0.0560241426006186,0,0,5.837953526294333,22.160492150347167,PRKN;HDAC4;NRG1
162,GO_Biological_Process_2018,negative regulation of protein secretion (GO:0050709),1/42,0.0290111592858413,0.0567764405655422,0,0,37.4202626641651,132.4705258751648,PRKN
702,GO_Biological_Process_2017b,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/33,0.022861068741375,0.0568544840002892,0,0,47.96634615384615,181.23219876999116,PRKN
164,GO_Biological_Process_2018,response to unfolded protein (GO:0006986),1/43,0.0296922795635159,0.0574050738227975,0,0,36.527472527472526,128.46230708138887,PRKN
163,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.0296922795635159,0.0574050738227975,0,0,36.527472527472526,128.46230708138887,NRG1
703,GO_Biological_Process_2017b,histone deacetylation (GO:0016575),1/34,0.0235461938251205,0.0580535468446937,0,0,46.51048951048951,174.35810878919273,HDAC4
704,GO_Biological_Process_2017b,regulation of heart rate by cardiac conduction (GO:0086091),1/34,0.0235461938251205,0.0580535468446937,0,0,46.51048951048951,174.35810878919273,KCND3
705,GO_Biological_Process_2017b,substrate localization to autophagosome (GO:0061753),1/34,0.0235461938251205,0.0580535468446937,0,0,46.51048951048951,174.35810878919273,ATG16L1
165,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),1/44,0.0303729561855169,0.0583673073685535,0,0,35.67620751341681,124.65989939397582,PTPRD
707,GO_Biological_Process_2017b,autophagosome assembly (GO:0000045),1/35,0.0242308728650598,0.0592310225590352,0,0,45.14027149321267,167.92757529985917,ATG16L1
708,GO_Biological_Process_2017b,positive regulation of dendritic spine morphogenesis (GO:0061003),1/35,0.0242308728650598,0.0592310225590352,0,0,45.14027149321267,167.92757529985917,PTPRD
706,GO_Biological_Process_2017b,response to type I interferon (GO:0034340),1/35,0.0242308728650598,0.0592310225590352,0,0,45.14027149321267,167.92757529985917,LIFR
166,GO_Biological_Process_2018,protein polymerization (GO:0051258),1/45,0.031053189424305,0.0593171702176844,0,0,34.86363636363637,121.04841961551216,PRKN
167,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0317329795488298,0.060254883786171,0,0,34.08717948717949,117.61436233167085,NRG1
711,GO_Biological_Process_2017b,cellular response to unfolded protein (GO:0034620),1/36,0.0249151061269709,0.0603874606128277,0,0,43.848351648351645,161.9004351330391,PRKN
709,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0249151061269709,0.0603874606128277,0,0,43.848351648351645,161.9004351330391,NRG1
710,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0249151061269709,0.0603874606128277,0,0,43.848351648351645,161.9004351330391,NRG1
713,GO_Biological_Process_2017b,negative regulation of JNK cascade (GO:0046329),1/37,0.025598893875467,0.0611806433012556,0,0,42.62820512820513,156.2411590204543,PRKN
714,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced cell death (GO:1903202),1/37,0.025598893875467,0.0611806433012556,0,0,42.62820512820513,156.2411590204543,PRKN
712,GO_Biological_Process_2017b,negative regulation of necrotic cell death (GO:0060547),1/37,0.025598893875467,0.0611806433012556,0,0,42.62820512820513,156.2411590204543,PRKN
715,GO_Biological_Process_2017b,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/37,0.025598893875467,0.0611806433012556,0,0,42.62820512820513,156.2411590204543,PRKN
716,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.025598893875467,0.0611806433012556,0,0,42.62820512820513,156.2411590204543,NRG1
168,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0324123268177389,0.0611806642299332,0,0,33.34448160535117,114.34544554475478,PTPRD
171,GO_Biological_Process_2018,cellular macromolecule catabolic process (GO:0044265),1/48,0.0330912315021826,0.0613726909836992,0,0,32.633387888707034,111.23047645903024,PRKN
170,GO_Biological_Process_2018,regulation of mitochondrion organization (GO:0010821),1/48,0.0330912315021826,0.0613726909836992,0,0,32.633387888707034,111.23047645903024,PRKN
169,GO_Biological_Process_2018,protein K48-linked ubiquitination (GO:0070936),1/48,0.0330912315021826,0.0613726909836992,0,0,32.633387888707034,111.23047645903024,PRKN
718,GO_Biological_Process_2017b,regulation of synaptic vesicle exocytosis (GO:2000300),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,PRKN
719,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,NRG1
721,GO_Biological_Process_2017b,response to interferon-beta (GO:0035456),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,LIFR
722,GO_Biological_Process_2017b,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,PRKN
717,GO_Biological_Process_2017b,histone H2A K63-linked ubiquitination (GO:0070535),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,PRKN
720,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),1/38,0.0262822363843274,0.0617812570349395,0,0,41.47401247401248,150.91820759135345,NRG1
172,GO_Biological_Process_2018,regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.033769693865094,0.061911105419339,0,0,31.95192307692308,108.25923449477123,PRKN
173,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.033769693865094,0.061911105419339,0,0,31.95192307692308,108.25923449477123,PRKN
175,GO_Biological_Process_2018,negative regulation of viral genome replication (GO:0045071),1/50,0.0344477141698711,0.0620837334473949,0,0,31.298273155416013,105.4223689491126,PRKN
174,GO_Biological_Process_2018,regulation of ion transport (GO:0043269),1/50,0.0344477141698711,0.0620837334473949,0,0,31.298273155416013,105.4223689491126,PRKN
176,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0344477141698711,0.0620837334473949,0,0,31.298273155416013,105.4223689491126,NRG1
725,GO_Biological_Process_2017b,histone monoubiquitination (GO:0010390),1/39,0.0269651339122192,0.0628697959149025,0,0,40.38056680161943,145.90349135778567,PRKN
724,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),1/39,0.0269651339122192,0.0628697959149025,0,0,40.38056680161943,145.90349135778567,NRG1
723,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0269651339122192,0.0628697959149025,0,0,40.38056680161943,145.90349135778567,NRG1
177,GO_Biological_Process_2018,response to organonitrogen compound (GO:0010243),1/51,0.035125292681812,0.062949260480326,0,0,30.67076923076923,102.71130924814014,PRKN
729,GO_Biological_Process_2017b,positive regulation of collagen binding (GO:0033343),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,PRKN
731,GO_Biological_Process_2017b,positive regulation of Ras GTPase binding (GO:1904477),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,PRKN
732,GO_Biological_Process_2017b,positive regulation of C-C chemokine binding (GO:2001265),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,PRKN
733,GO_Biological_Process_2017b,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,RBFOX1
727,GO_Biological_Process_2017b,response to interferon-alpha (GO:0035455),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,LIFR
728,GO_Biological_Process_2017b,engulfment of target by autophagosome (GO:0061736),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,ATG16L1
730,GO_Biological_Process_2017b,positive regulation of apolipoprotein binding (GO:2000658),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,PRKN
726,GO_Biological_Process_2017b,positive regulation of actin binding (GO:1904618),1/40,0.0276475867285054,0.0630894399283449,0,0,39.34319526627219,141.17191556098328,PRKN
179,GO_Biological_Process_2018,B cell differentiation (GO:0030183),1/52,0.035802429669446,0.0630993097489131,0,0,30.06787330316742,100.11818602041404,HDAC4
180,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),1/52,0.035802429669446,0.0630993097489131,0,0,30.06787330316742,100.11818602041404,PTPRD
178,GO_Biological_Process_2018,regulation of DNA binding (GO:0051101),1/52,0.035802429669446,0.0630993097489131,0,0,30.06787330316742,100.11818602041404,PRKN
737,GO_Biological_Process_2017b,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/41,0.0283295950973344,0.0639652436671394,0,0,38.35769230769231,136.70099489654157,PRKN
736,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),1/41,0.0283295950973344,0.0639652436671394,0,0,38.35769230769231,136.70099489654157,NRG1
734,GO_Biological_Process_2017b,positive regulation of protein targeting to membrane (GO:0090314),1/41,0.0283295950973344,0.0639652436671394,0,0,38.35769230769231,136.70099489654157,PRKN
735,GO_Biological_Process_2017b,positive regulation of heparan sulfate proteoglycan binding (GO:1905860),1/41,0.0283295950973344,0.0639652436671394,0,0,38.35769230769231,136.70099489654157,PRKN
738,GO_Biological_Process_2017b,positive regulation of microtubule binding (GO:1904528),1/42,0.0290111592858413,0.0646534406941606,0,0,37.4202626641651,132.4705258751648,PRKN
739,GO_Biological_Process_2017b,suppression by virus of host protein phosphorylation (GO:0039613),1/42,0.0290111592858413,0.0646534406941606,0,0,37.4202626641651,132.4705258751648,PRKN
740,GO_Biological_Process_2017b,regulation of autophagy (GO:0010506),1/42,0.0290111592858413,0.0646534406941606,0,0,37.4202626641651,132.4705258751648,PRKN
741,GO_Biological_Process_2017b,positive regulation of receptor binding (GO:1900122),1/42,0.0290111592858413,0.0646534406941606,0,0,37.4202626641651,132.4705258751648,PRKN
742,GO_Biological_Process_2017b,regulation of protein targeting to vacuole involved in autophagy (GO:1904051),1/42,0.0290111592858413,0.0646534406941606,0,0,37.4202626641651,132.4705258751648,PRKN
181,GO_Biological_Process_2018,negative regulation of supramolecular fiber organization (GO:1902904),1/54,0.0371553801227102,0.0651239904348602,0,0,28.93033381712627,95.25736807729456,PRKN
743,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),3/991,0.0293071300451481,0.0651438279241894,0,0,5.244203165255797,18.51164095446436,PRKN;HDAC4;NRG1
745,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0296922795635159,0.0651559485051066,0,0,36.527472527472526,128.46230708138887,PTPRD
744,GO_Biological_Process_2017b,epidermal growth factor catabolic process (GO:0007174),1/43,0.0296922795635159,0.0651559485051066,0,0,36.527472527472526,128.46230708138887,PRKN
747,GO_Biological_Process_2017b,B cell proliferation (GO:0042100),1/43,0.0296922795635159,0.0651559485051066,0,0,36.527472527472526,128.46230708138887,HDAC4
748,GO_Biological_Process_2017b,negative regulation of cell death (GO:0060548),1/43,0.0296922795635159,0.0651559485051066,0,0,36.527472527472526,128.46230708138887,PRKN
746,GO_Biological_Process_2017b,negative regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901408),1/43,0.0296922795635159,0.0651559485051066,0,0,36.527472527472526,128.46230708138887,PRKN
182,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),2/444,0.037516145645437,0.0653969970540679,0,0,7.369532428355957,24.194056225278377,HDAC4;NRG1
183,GO_Biological_Process_2018,regulation of cellular catabolic process (GO:0031329),1/55,0.0378311941186609,0.0655877767600698,0,0,28.39316239316239,92.97685364985718,PRKN
749,GO_Biological_Process_2017b,positive regulation of elastin catabolic process (GO:0110015),1/44,0.0303729561855169,0.0659746744485405,0,0,35.67620751341681,124.65989939397582,PRKN
750,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0303729561855169,0.0659746744485405,0,0,35.67620751341681,124.65989939397582,PTPRD
751,GO_Biological_Process_2017b,negative regulation of protein ubiquitination (GO:0031397),1/44,0.0303729561855169,0.0659746744485405,0,0,35.67620751341681,124.65989939397582,PRKN
752,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0303729561855169,0.0659746744485405,0,0,35.67620751341681,124.65989939397582,NRG1
184,GO_Biological_Process_2018,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/56,0.0385065676493855,0.0660408337642687,0,0,27.875524475524475,90.78853336057628,PRKN
185,GO_Biological_Process_2018,autophagosome organization (GO:1905037),1/56,0.0385065676493855,0.0660408337642687,0,0,27.875524475524475,90.78853336057628,ATG16L1
186,GO_Biological_Process_2018,regulation of glycolytic process (GO:0006110),1/57,0.0391815009686787,0.0668390310642167,0,0,27.376373626373628,88.68714644738452,HDAC4
754,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.031053189424305,0.0671124345744426,0,0,34.86363636363637,121.04841961551216,NRG1
753,GO_Biological_Process_2017b,RNA import into mitochondrion (GO:0035927),1/45,0.031053189424305,0.0671124345744426,0,0,34.86363636363637,121.04841961551216,RBFOX1
188,GO_Biological_Process_2018,autophagosome assembly (GO:0000045),1/58,0.0398559943558669,0.0672701703678389,0,0,26.894736842105264,86.66781779581883,ATG16L1
187,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/58,0.0398559943558669,0.0672701703678389,0,0,26.894736842105264,86.66781779581883,PTPRD
763,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
759,GO_Biological_Process_2017b,response to interferon-gamma (GO:0034341),1/47,0.0324123268177389,0.0679241067676381,0,0,33.34448160535117,114.34544554475478,LIFR
760,GO_Biological_Process_2017b,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0324123268177389,0.0679241067676381,0,0,33.34448160535117,114.34544554475478,PTPRD
775,GO_Biological_Process_2017b,negative regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904324),1/48,0.0330912315021826,0.0679241067676381,0,0,32.633387888707034,111.23047645903024,PRKN
774,GO_Biological_Process_2017b,response to tumor necrosis factor (GO:0034612),1/48,0.0330912315021826,0.0679241067676381,0,0,32.633387888707034,111.23047645903024,LIFR
773,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",2/414,0.0330036623356586,0.0679241067676381,0,0,7.918284789644013,27.01035219386713,HDAC4;NRG1
772,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),2/413,0.0328572891308671,0.0679241067676381,0,0,7.937956204379562,27.112737687629508,HDAC4;NRG1
762,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
771,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),2/413,0.0328572891308671,0.0679241067676381,0,0,7.937956204379562,27.112737687629508,HDAC4;NRG1
769,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
758,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.0324123268177389,0.0679241067676381,0,0,33.34448160535117,114.34544554475478,NRG1
767,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
766,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
765,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
764,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
770,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),2/413,0.0328572891308671,0.0679241067676381,0,0,7.937956204379562,27.112737687629508,HDAC4;NRG1
768,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
761,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",2/412,0.0327111808295531,0.0679241067676381,0,0,7.957723577235773,27.215719718368767,HDAC4;NRG1
755,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0317329795488298,0.0679241067676381,0,0,34.08717948717949,117.61436233167085,PTPRD
756,GO_Biological_Process_2017b,negative regulation of histone phosphorylation (GO:0033128),1/46,0.0317329795488298,0.0679241067676381,0,0,34.08717948717949,117.61436233167085,PRKN
757,GO_Biological_Process_2017b,negative regulation of programmed cell death (GO:0043069),1/47,0.0324123268177389,0.0679241067676381,0,0,33.34448160535117,114.34544554475478,PRKN
776,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),2/416,0.0332972019188146,0.0681837690843508,0,0,7.879227053140097,26.807351683346496,HDAC4;NRG1
781,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.033769693865094,0.068335842774176,0,0,31.95192307692308,108.25923449477123,NRG1
780,GO_Biological_Process_2017b,B cell lineage commitment (GO:0002326),1/49,0.033769693865094,0.068335842774176,0,0,31.95192307692308,108.25923449477123,HDAC4
779,GO_Biological_Process_2017b,modulation by virus of host autophagy (GO:0039519),1/49,0.033769693865094,0.068335842774176,0,0,31.95192307692308,108.25923449477123,PRKN
778,GO_Biological_Process_2017b,mature B cell differentiation (GO:0002335),1/49,0.033769693865094,0.068335842774176,0,0,31.95192307692308,108.25923449477123,HDAC4
777,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),2/419,0.0337394884751659,0.068335842774176,0,0,7.821342925659472,26.507206647843077,HDAC4;NRG1
189,GO_Biological_Process_2018,positive regulation of protein binding (GO:0032092),1/60,0.0412036623612398,0.0688165879226989,0,0,25.980443285528036,82.85756066816143,PRKN
190,GO_Biological_Process_2018,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/60,0.0412036623612398,0.0688165879226989,0,0,25.980443285528036,82.85756066816143,RBFOX1
782,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",2/422,0.0341841384607412,0.0690117430572141,0,0,7.764285714285714,26.212178338006115,HDAC4;NRG1
784,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.0344477141698711,0.0691248897093926,0,0,31.298273155416013,105.4223689491126,NRG1
785,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",2/424,0.0344818797151748,0.0691248897093926,0,0,7.726698262243286,26.01827578061912,HDAC4;NRG1
783,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),2/423,0.0343328785486466,0.0691248897093926,0,0,7.745447347585115,26.1149516900718,HDAC4;NRG1
192,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/62,0.0425495737837072,0.0692853114842321,0,0,25.12610340479193,79.32525524448647,PRKN
191,GO_Biological_Process_2018,potassium ion transport (GO:0006813),1/61,0.041876837511306,0.0692853114842321,0,0,25.54615384615385,81.05851861588675,KCND3
194,GO_Biological_Process_2018,cellular protein catabolic process (GO:0044257),1/62,0.0425495737837072,0.0692853114842321,0,0,25.12610340479193,79.32525524448647,PRKN
195,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),2/479,0.0430679988065276,0.0692853114842321,0,0,6.816561844863732,21.43791689302339,PRKN;NRG1
196,GO_Biological_Process_2018,negative regulation of neuron apoptotic process (GO:0043524),1/63,0.0432218714274676,0.0692853114842321,0,0,24.719602977667492,77.65437409472437,PRKN
197,GO_Biological_Process_2018,negative regulation of protein modification process (GO:0031400),1/63,0.0432218714274676,0.0692853114842321,0,0,24.719602977667492,77.65437409472437,PRKN
198,GO_Biological_Process_2018,oligosaccharide metabolic process (GO:0009311),1/63,0.0432218714274676,0.0692853114842321,0,0,24.719602977667492,77.65437409472437,GALNTL6
193,GO_Biological_Process_2018,positive regulation of catabolic process (GO:0009896),1/62,0.0425495737837072,0.0692853114842321,0,0,25.12610340479193,79.32525524448647,PRKN
337,WikiPathways_2019_Human,Genes targeted by miRNAs in adipocytes WP1992,1/13,0.0090644890278939,0.06949441588052,0,0,128.03846153846155,602.2149225510485,HDAC4
786,GO_Biological_Process_2017b,immature B cell differentiation (GO:0002327),1/51,0.035125292681812,0.0700872119092899,0,0,30.67076923076923,102.71130924814014,HDAC4
787,GO_Biological_Process_2017b,negative regulation by host of viral genome replication (GO:0044828),1/51,0.035125292681812,0.0700872119092899,0,0,30.67076923076923,102.71130924814014,PRKN
200,GO_Biological_Process_2018,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/65,0.0445651519182939,0.0703776409006721,0,0,23.94471153846154,74.4872822237409,HDAC4
201,GO_Biological_Process_2018,negative regulation of apoptotic signaling pathway (GO:2001234),1/65,0.0445651519182939,0.0703776409006721,0,0,23.94471153846154,74.4872822237409,PRKN
199,GO_Biological_Process_2018,O-glycan processing (GO:0016266),1/65,0.0445651519182939,0.0703776409006721,0,0,23.94471153846154,74.4872822237409,GALNTL6
788,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),2/430,0.0353813480540405,0.0704343309289252,0,0,7.616043613707165,25.44954658118408,HDAC4;NRG1
789,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),2/432,0.0356832422361608,0.0708708838857084,0,0,7.57984496124031,25.26418496440269,HDAC4;NRG1
790,GO_Biological_Process_2017b,mitochondrion to lysosome transport (GO:0099074),1/52,0.035802429669446,0.0709433825782556,0,0,30.06787330316742,100.11818602041404,PRKN
202,GO_Biological_Process_2018,positive regulation of cellular protein localization (GO:1903829),1/66,0.0452361352854174,0.0710853554485131,0,0,23.57514792899408,72.98533526719285,PRKN
203,GO_Biological_Process_2018,positive regulation of autophagy (GO:0010508),1/67,0.0459066810912919,0.0717854473927554,0,0,23.216783216783217,71.53426658516943,PRKN
791,GO_Biological_Process_2017b,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/53,0.0364791253950767,0.0721177179469488,0,0,29.48816568047337,97.63576151436207,PRKN
341,WikiPathways_2019_Human,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,1/32,0.0221754973519546,0.0728623484421366,0,0,49.516129032258064,188.59541419671356,HDAC4
338,WikiPathways_2019_Human,Nanoparticle triggered autophagic cell death WP2509,1/23,0.015985227036696,0.0728623484421366,0,0,69.8041958041958,288.7164567086745,ATG16L1
339,WikiPathways_2019_Human,Physiological and Pathological Hypertrophy  of the Heart WP1528,1/25,0.0173639786153884,0.0728623484421366,0,0,63.98076923076923,259.3369252570107,LIFR
340,WikiPathways_2019_Human,Ethanol effects on histone modifications WP3996,1/31,0.0214894793855565,0.0728623484421366,0,0,51.16923076923077,196.4996601316088,HDAC4
792,GO_Biological_Process_2017b,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/54,0.0371553801227102,0.072950380195161,0,0,28.93033381712627,95.25736807729456,HDAC4
793,GO_Biological_Process_2017b,cellular response to cytokine stimulus (GO:0071345),1/54,0.0371553801227102,0.072950380195161,0,0,28.93033381712627,95.25736807729456,LIFR
794,GO_Biological_Process_2017b,negative regulation of protein binding (GO:0032091),1/54,0.0371553801227102,0.072950380195161,0,0,28.93033381712627,95.25736807729456,HDAC4
342,WikiPathways_2019_Human,Parkinsons Disease Pathway WP2371,1/38,0.0262822363843274,0.0732141781514829,0,0,41.47401247401248,150.91820759135345,PRKN
343,WikiPathways_2019_Human,ATM Signaling Network in Development and Disease  WP3878,1/45,0.031053189424305,0.0732141781514829,0,0,34.86363636363637,121.04841961551216,HDAC4
344,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0364791253950767,0.0732141781514829,0,0,29.48816568047337,97.63576151436207,NRG1
345,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,1/53,0.0364791253950767,0.0732141781514829,0,0,29.48816568047337,97.63576151436207,NRG1
346,WikiPathways_2019_Human,MECP2 and Associated Rett Syndrome WP3584,1/62,0.0425495737837072,0.0732141781514829,0,0,25.12610340479193,79.32525524448647,RBFOX1
347,WikiPathways_2019_Human,Endochondral Ossification WP474,1/64,0.0438937307216496,0.0732141781514829,0,0,24.326007326007325,76.04270426665417,HDAC4
348,WikiPathways_2019_Human,Oncostatin M Signaling Pathway WP2374,1/65,0.0445651519182939,0.0732141781514829,0,0,23.94471153846154,74.4872822237409,LIFR
349,WikiPathways_2019_Human,Parkin-Ubiquitin Proteasomal System pathway WP2359,1/70,0.0479156957277768,0.0734707334492578,0,0,22.204013377926422,67.46272365268403,PRKN
205,GO_Biological_Process_2018,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/70,0.0479156957277768,0.0738410963147865,0,0,22.204013377926422,67.46272365268403,PRKN
206,GO_Biological_Process_2018,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/70,0.0479156957277768,0.0738410963147865,0,0,22.204013377926422,67.46272365268403,PRKN
204,GO_Biological_Process_2018,negative regulation of developmental process (GO:0051093),1/70,0.0479156957277768,0.0738410963147865,0,0,22.204013377926422,67.46272365268403,PRKN
795,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),1/55,0.0378311941186609,0.0741076816297057,0,0,28.39316239316239,92.97685364985718,NRG1
207,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/512,0.0485724995703776,0.0744934007834157,0,0,6.364705882352941,19.251311629815994,HDAC4;NRG1
819,GO_Biological_Process_2017b,Rohon-Beard neuron differentiation (GO:1905275),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
820,GO_Biological_Process_2017b,medial motor column neuron differentiation (GO:0021526),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
821,GO_Biological_Process_2017b,glutamatergic neuron differentiation (GO:1905962),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
822,GO_Biological_Process_2017b,neuron differentiation involved in amphid sensory organ development (GO:0003387),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
823,GO_Biological_Process_2017b,response to manganese-induced endoplasmic reticulum stress (GO:1990737),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PRKN
824,GO_Biological_Process_2017b,mechanoreceptor differentiation (GO:0042490),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
825,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
826,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
827,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
828,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
829,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
830,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
831,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
832,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
833,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
834,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
835,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
818,GO_Biological_Process_2017b,neuron differentiation involved in salivary gland development (GO:0060705),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
836,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
817,GO_Biological_Process_2017b,retinal bipolar neuron differentiation (GO:0060040),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
815,GO_Biological_Process_2017b,endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857),1/62,0.0425495737837072,0.074496360988269,0,0,25.12610340479193,79.32525524448647,PRKN
798,GO_Biological_Process_2017b,positive regulation of transcription factor catabolic process (GO:1901485),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,PRKN
799,GO_Biological_Process_2017b,positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,PRKN
800,GO_Biological_Process_2017b,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,PRKN
801,GO_Biological_Process_2017b,negative regulation of CREB transcription factor activity (GO:0032792),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,HDAC4
802,GO_Biological_Process_2017b,negative regulation of JUN kinase activity (GO:0043508),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,PRKN
803,GO_Biological_Process_2017b,protein localization to pre-autophagosomal structure (GO:0034497),1/58,0.0398559943558669,0.074496360988269,0,0,26.894736842105264,86.66781779581883,ATG16L1
804,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.040530048064478,0.074496360988269,0,0,26.42970822281167,84.7260236205579,PTPRD
805,GO_Biological_Process_2017b,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/59,0.040530048064478,0.074496360988269,0,0,26.42970822281167,84.7260236205579,PRKN
806,GO_Biological_Process_2017b,proteasomal protein catabolic process (GO:0010498),1/59,0.040530048064478,0.074496360988269,0,0,26.42970822281167,84.7260236205579,PRKN
807,GO_Biological_Process_2017b,response to endoplasmic reticulum stress (GO:0034976),1/60,0.0412036623612398,0.074496360988269,0,0,25.980443285528036,82.85756066816143,PRKN
808,GO_Biological_Process_2017b,positive regulation of protein ubiquitination (GO:0031398),1/60,0.0412036623612398,0.074496360988269,0,0,25.980443285528036,82.85756066816143,PRKN
809,GO_Biological_Process_2017b,negative regulation of outer hair cell apoptotic process (GO:1905586),1/60,0.0412036623612398,0.074496360988269,0,0,25.980443285528036,82.85756066816143,PRKN
810,GO_Biological_Process_2017b,positive regulation of protein catabolic process (GO:0045732),1/60,0.0412036623612398,0.074496360988269,0,0,25.980443285528036,82.85756066816143,PRKN
811,GO_Biological_Process_2017b,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/61,0.041876837511306,0.074496360988269,0,0,25.54615384615385,81.05851861588675,PRKN
812,GO_Biological_Process_2017b,B cell differentiation (GO:0030183),1/61,0.041876837511306,0.074496360988269,0,0,25.54615384615385,81.05851861588675,HDAC4
813,GO_Biological_Process_2017b,negative regulation of motor neuron apoptotic process (GO:2000672),1/62,0.0425495737837072,0.074496360988269,0,0,25.12610340479193,79.32525524448647,PRKN
814,GO_Biological_Process_2017b,regulation of translation in response to endoplasmic reticulum stress (GO:0036490),1/62,0.0425495737837072,0.074496360988269,0,0,25.12610340479193,79.32525524448647,PRKN
816,GO_Biological_Process_2017b,photoreceptor cell differentiation (GO:0046530),1/63,0.0432218714274676,0.074496360988269,0,0,24.719602977667492,77.65437409472437,PTPRD
797,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0391815009686787,0.074496360988269,0,0,27.376373626373628,88.68714644738452,PTPRD
837,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
839,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
861,GO_Biological_Process_2017b,GABAergic neuron differentiation (GO:0097154),1/64,0.0438937307216496,0.074496360988269,0,0,24.326007326007325,76.04270426665417,PTPRD
862,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/485,0.0440497332704614,0.074496360988269,0,0,6.729813664596273,21.01341233695891,PRKN;HDAC4
863,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),2/487,0.0443788868138811,0.074496360988269,0,0,6.701374570446736,20.874724455679488,PRKN;HDAC4
864,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),2/488,0.0445438198504153,0.074496360988269,0,0,6.68724279835391,20.805897202470167,PRKN;HDAC4
865,GO_Biological_Process_2017b,ER overload response (GO:0006983),1/65,0.0445651519182939,0.074496360988269,0,0,23.94471153846154,74.4872822237409,PRKN
866,GO_Biological_Process_2017b,mitochondrion disassembly (GO:0061726),1/65,0.0445651519182939,0.074496360988269,0,0,23.94471153846154,74.4872822237409,PRKN
867,GO_Biological_Process_2017b,potassium ion transport (GO:0006813),1/65,0.0445651519182939,0.074496360988269,0,0,23.94471153846154,74.4872822237409,KCND3
868,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),2/491,0.0450400396923927,0.074496360988269,0,0,6.64519427402863,20.60145397424781,PRKN;HDAC4
869,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),2/492,0.0452059186898242,0.074496360988269,0,0,6.631292517006803,20.5339780230868,PRKN;HDAC4
870,GO_Biological_Process_2017b,mitochondrial membrane organization (GO:0007006),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,PRKN
871,GO_Biological_Process_2017b,negative regulation of androgen receptor activity (GO:2000824),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,HDAC4
872,GO_Biological_Process_2017b,cardiac neuron differentiation (GO:0060945),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,PTPRD
873,GO_Biological_Process_2017b,positive regulation of cellular protein catabolic process (GO:1903364),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,PRKN
874,GO_Biological_Process_2017b,chromatin remodeling (GO:0006338),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,HDAC4
875,GO_Biological_Process_2017b,chromatin remodeling in response to cation stress (GO:0043156),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,HDAC4
876,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,NRG1
877,GO_Biological_Process_2017b,chromatin remodeling at centromere (GO:0031055),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,HDAC4
860,GO_Biological_Process_2017b,sperm mitochondrion organization (GO:0030382),1/64,0.0438937307216496,0.074496360988269,0,0,24.326007326007325,76.04270426665417,PRKN
838,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
859,GO_Biological_Process_2017b,mitochondrion organization (GO:0007005),1/64,0.0438937307216496,0.074496360988269,0,0,24.326007326007325,76.04270426665417,PRKN
857,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),2/484,0.0438855134874553,0.074496360988269,0,0,6.744121715076072,21.083277741352862,PRKN;HDAC4
840,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
841,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
842,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
843,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
844,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
845,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
846,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
847,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
848,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),2/481,0.043394286379107,0.074496360988269,0,0,6.787404314544189,21.29498892830525,PRKN;HDAC4
849,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),2/482,0.0435577896812901,0.074496360988269,0,0,6.772916666666666,21.224063583708435,PRKN;HDAC4
850,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),2/482,0.0435577896812901,0.074496360988269,0,0,6.772916666666666,21.224063583708435,PRKN;HDAC4
851,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),2/482,0.0435577896812901,0.074496360988269,0,0,6.772916666666666,21.224063583708435,PRKN;HDAC4
852,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),2/482,0.0435577896812901,0.074496360988269,0,0,6.772916666666666,21.224063583708435,PRKN;HDAC4
853,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),2/483,0.0437215321658237,0.074496360988269,0,0,6.758489258489258,21.15349401028168,PRKN;HDAC4
854,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),2/484,0.0438855134874553,0.074496360988269,0,0,6.744121715076072,21.083277741352862,PRKN;HDAC4
855,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),2/484,0.0438855134874553,0.074496360988269,0,0,6.744121715076072,21.083277741352862,PRKN;HDAC4
856,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),2/484,0.0438855134874553,0.074496360988269,0,0,6.744121715076072,21.083277741352862,PRKN;HDAC4
858,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),2/484,0.0438855134874553,0.074496360988269,0,0,6.744121715076072,21.083277741352862,PRKN;HDAC4
796,GO_Biological_Process_2017b,regulation of chaperone-mediated autophagy (GO:1904714),1/56,0.0385065676493855,0.074496360988269,0,0,27.875524475524475,90.78853336057628,PRKN
878,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441),1/66,0.0452361352854174,0.074496360988269,0,0,23.57514792899408,72.98533526719285,PRKN
209,GO_Biological_Process_2018,lysosomal transport (GO:0007041),1/72,0.0492528558004378,0.0747639876504282,0,0,21.57638136511376,64.9619085278147,PRKN
208,GO_Biological_Process_2018,regulation of neuron death (GO:1901214),1/72,0.0492528558004378,0.0747639876504282,0,0,21.57638136511376,64.9619085278147,PRKN
212,GO_Biological_Process_2018,positive regulation of proteasomal protein catabolic process (GO:1901800),1/73,0.0499207817226997,0.0747639876504282,0,0,21.275641025641026,63.76985958511893,PRKN
211,GO_Biological_Process_2018,B cell activation (GO:0042113),1/73,0.0499207817226997,0.0747639876504282,0,0,21.275641025641026,63.76985958511893,HDAC4
210,GO_Biological_Process_2018,lymphocyte differentiation (GO:0030098),1/73,0.0499207817226997,0.0747639876504282,0,0,21.275641025641026,63.76985958511893,HDAC4
882,GO_Biological_Process_2017b,noradrenergic neuron differentiation (GO:0003357),1/67,0.0459066810912919,0.0750246330977685,0,0,23.216783216783217,71.53426658516943,PTPRD
880,GO_Biological_Process_2017b,nucleosome mobilization (GO:0042766),1/67,0.0459066810912919,0.0750246330977685,0,0,23.216783216783217,71.53426658516943,HDAC4
879,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),2/496,0.0458717870618506,0.0750246330977685,0,0,6.576248313090418,20.26737263534259,PRKN;HDAC4
881,GO_Biological_Process_2017b,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/67,0.0459066810912919,0.0750246330977685,0,0,23.216783216783217,71.53426658516943,PRKN
213,GO_Biological_Process_2018,"regulation of gene expression, epigenetic (GO:0040029)",1/74,0.0505882719129409,0.0754096202814399,0,0,20.98314014752371,62.6144353100612,HDAC4
883,GO_Biological_Process_2017b,mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),1/68,0.0465767895867937,0.0756872830785398,0,0,22.8691159586682,70.13164167770657,PRKN
884,GO_Biological_Process_2017b,neuron fate commitment (GO:0048663),1/68,0.0465767895867937,0.0756872830785398,0,0,22.8691159586682,70.13164167770657,PTPRD
885,GO_Biological_Process_2017b,amacrine cell differentiation (GO:0035881),1/68,0.0465767895867937,0.0756872830785398,0,0,22.8691159586682,70.13164167770657,PTPRD
214,GO_Biological_Process_2018,gland development (GO:0048732),1/75,0.0512553266419403,0.0760486009245534,0,0,20.698544698544698,61.494046042978006,NRG1
886,GO_Biological_Process_2017b,negative regulation of thyroid hormone receptor activity (GO:1904168),1/69,0.0472464610426502,0.0766303659255083,0,0,22.5316742081448,68.77517598546079,HDAC4
215,GO_Biological_Process_2018,response to interleukin-1 (GO:0070555),1/76,0.0519219461635218,0.0766810223433494,0,0,20.42153846153846,60.40719102216577,HDAC4
216,GO_Biological_Process_2018,ERAD pathway (GO:0036503),1/77,0.0525881307391528,0.0773069756027178,0,0,20.15182186234818,59.35245231348692,PRKN
888,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912),1/70,0.0479156957277768,0.077423101571436,0,0,22.204013377926422,67.46272365268403,PRKN
887,GO_Biological_Process_2017b,neuron differentiation (GO:0030182),1/70,0.0479156957277768,0.077423101571436,0,0,22.204013377926422,67.46272365268403,PTPRD
889,GO_Biological_Process_2017b,negative regulation of neuron death (GO:1901215),1/71,0.0485844938901796,0.0782091852866306,0,0,21.88571428571429,66.19226727807713,PRKN
890,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,0.0485844938901796,0.0782091852866306,0,0,21.88571428571429,66.19226727807713,PRKN
892,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PRKN
893,GO_Biological_Process_2017b,mitochondrial genome maintenance (GO:0000002),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PRKN
894,GO_Biological_Process_2017b,hair cell differentiation (GO:0035315),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PTPRD
895,GO_Biological_Process_2017b,mitochondrion distribution (GO:0048311),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PRKN
891,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PRKN
897,GO_Biological_Process_2017b,mitochondrion morphogenesis (GO:0070584),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,PRKN
896,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0492528558004378,0.0782573153273623,0,0,21.57638136511376,64.9619085278147,NRG1
898,GO_Biological_Process_2017b,RNA export from nucleus (GO:0006405),1/73,0.0499207817226997,0.0785908820515163,0,0,21.275641025641026,63.76985958511893,RBFOX1
899,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion (GO:1903599),1/73,0.0499207817226997,0.0785908820515163,0,0,21.275641025641026,63.76985958511893,PRKN
900,GO_Biological_Process_2017b,negative regulation of autophagy (GO:0010507),1/73,0.0499207817226997,0.0785908820515163,0,0,21.275641025641026,63.76985958511893,PRKN
901,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),1/73,0.0499207817226997,0.0785908820515163,0,0,21.275641025641026,63.76985958511893,NRG1
902,GO_Biological_Process_2017b,negative regulation of I-kappaB phosphorylation (GO:1903720),1/73,0.0499207817226997,0.0785908820515163,0,0,21.275641025641026,63.76985958511893,PRKN
219,GO_Biological_Process_2018,positive regulation of binding (GO:0051099),1/81,0.0552485248803981,0.0786798189144955,0,0,19.140384615384612,55.42890084307133,PRKN
220,GO_Biological_Process_2018,positive regulation of protein catabolic process (GO:0045732),1/81,0.0552485248803981,0.0786798189144955,0,0,19.140384615384612,55.42890084307133,PRKN
221,GO_Biological_Process_2018,protein catabolic process (GO:0030163),1/81,0.0552485248803981,0.0786798189144955,0,0,19.140384615384612,55.42890084307133,PRKN
222,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.0552485248803981,0.0786798189144955,0,0,19.140384615384612,55.42890084307133,NRG1
223,GO_Biological_Process_2018,negative regulation of cell death (GO:0060548),1/81,0.0552485248803981,0.0786798189144955,0,0,19.140384615384612,55.42890084307133,PRKN
217,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),1/80,0.0545840774557414,0.0786798189144955,0,0,19.383641674780915,56.36788314936266,NRG1
218,GO_Biological_Process_2018,RNA transport (GO:0050658),1/80,0.0545840774557414,0.0786798189144955,0,0,19.383641674780915,56.36788314936266,RBFOX1
903,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/74,0.0505882719129409,0.0794958558631928,0,0,20.98314014752371,62.6144353100612,PRKN
224,GO_Biological_Process_2018,negative regulation of neuron death (GO:1901215),1/83,0.0565761190901678,0.0802123643989491,0,0,18.67166979362101,53.62817822019501,PRKN
905,GO_Biological_Process_2017b,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/75,0.0512553266419403,0.0802501282094614,0,0,20.698544698544698,61.494046042978006,PRKN
904,GO_Biological_Process_2017b,ATP-dependent chromatin remodeling (GO:0043044),1/75,0.0512553266419403,0.0802501282094614,0,0,20.698544698544698,61.494046042978006,HDAC4
906,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0519219461635218,0.0809982360150941,0,0,20.42153846153846,60.40719102216577,NRG1
907,GO_Biological_Process_2017b,negative regulation of protein phosphorylation (GO:0001933),1/76,0.0519219461635218,0.0809982360150941,0,0,20.42153846153846,60.40719102216577,PRKN
908,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),2/534,0.0523812020149133,0.081566372647542,0,0,6.094611528822055,17.974273982796863,PRKN;HDAC4
909,GO_Biological_Process_2017b,peripheral nervous system neuron differentiation (GO:0048934),1/77,0.0525881307391528,0.08159243431138,0,0,20.15182186234818,59.35245231348692,PTPRD
910,GO_Biological_Process_2017b,regulation of autophagy of mitochondrion (GO:1903146),1/77,0.0525881307391528,0.08159243431138,0,0,20.15182186234818,59.35245231348692,PRKN
225,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/565,0.0579285963287453,0.0817664700392468,0,0,5.749851983422143,16.378707084923164,PRKN;HDAC4
915,GO_Biological_Process_2017b,negative regulation of insulin secretion (GO:0046676),1/78,0.0532538806466596,0.0818849992738959,0,0,19.88911088911089,58.32848923315731,PRKN
914,GO_Biological_Process_2017b,dopaminergic neuron differentiation (GO:0071542),1/78,0.0532538806466596,0.0818849992738959,0,0,19.88911088911089,58.32848923315731,PTPRD
913,GO_Biological_Process_2017b,mitochondrial respiratory chain supercomplex assembly (GO:0097250),1/78,0.0532538806466596,0.0818849992738959,0,0,19.88911088911089,58.32848923315731,PRKN
912,GO_Biological_Process_2017b,heterochromatin assembly (GO:0031507),1/78,0.0532538806466596,0.0818849992738959,0,0,19.88911088911089,58.32848923315731,HDAC4
911,GO_Biological_Process_2017b,positive regulation of autophagy (GO:0010508),1/78,0.0532538806466596,0.0818849992738959,0,0,19.88911088911089,58.32848923315731,PRKN
917,GO_Biological_Process_2017b,mitochondrial fission (GO:0000266),1/79,0.0539191961302489,0.0826119112138457,0,0,19.633136094674555,57.33403323345184,PRKN
916,GO_Biological_Process_2017b,mitochondrial protein catabolic process (GO:0035694),1/79,0.0539191961302489,0.0826119112138457,0,0,19.633136094674555,57.33403323345184,PRKN
226,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.0592261122301625,0.0832296467022989,0,0,17.79964221824687,50.30877970707926,PTPRD
918,GO_Biological_Process_2017b,ERAD pathway (GO:0036503),1/80,0.0545840774557414,0.083481530226428,0,0,19.383641674780915,56.36788314936266,PRKN
227,GO_Biological_Process_2018,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/88,0.0598875296892885,0.0837900086442239,0,0,17.594164456233422,49.53262213559414,PRKN
228,GO_Biological_Process_2018,regulation of neuron apoptotic process (GO:0043523),1/89,0.0605485153373022,0.0839781582286931,0,0,17.393356643356643,48.77636968918565,PRKN
229,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),1/89,0.0605485153373022,0.0839781582286931,0,0,17.393356643356643,48.77636968918565,GALNTL6
231,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),1/90,0.0612090694238439,0.0841624704577854,0,0,17.197061365600693,48.03930144720859,PRKN
230,GO_Biological_Process_2018,regulation of cytokine-mediated signaling pathway (GO:0001959),1/90,0.0612090694238439,0.0841624704577854,0,0,17.197061365600693,48.03930144720859,LIFR
232,GO_Biological_Process_2018,regulation of protein catabolic process (GO:0042176),1/91,0.061869192229165,0.0847050314210457,0,0,17.005128205128205,47.32073015810725,PRKN
919,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0559125386720864,0.0852095171947605,0,0,18.903133903133902,54.51600716299186,NRG1
920,GO_Biological_Process_2017b,mitochondrial respiratory chain complex assembly (GO:0033108),1/82,0.0559125386720864,0.0852095171947605,0,0,18.903133903133902,54.51600716299186,PRKN
921,GO_Biological_Process_2017b,positive regulation of chaperone-mediated autophagy (GO:1904716),1/83,0.0565761190901678,0.08576379890347,0,0,18.67166979362101,53.62817822019501,PRKN
922,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0565761190901678,0.08576379890347,0,0,18.67166979362101,53.62817822019501,PTPRD
923,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0565761190901678,0.08576379890347,0,0,18.67166979362101,53.62817822019501,PTPRD
233,GO_Biological_Process_2018,proteolysis involved in cellular protein catabolic process (GO:0051603),1/93,0.0631881450049838,0.0861411036606403,0,0,16.63377926421405,45.93648645509872,PRKN
924,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0572392663874041,0.0861601588778819,0,0,18.44578313253012,52.764441934672654,NRG1
925,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0572392663874041,0.0861601588778819,0,0,18.44578313253012,52.764441934672654,NRG1
926,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0572392663874041,0.0861601588778819,0,0,18.44578313253012,52.764441934672654,NRG1
927,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0572392663874041,0.0861601588778819,0,0,18.44578313253012,52.764441934672654,PTPRD
234,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),1/95,0.0645053757251089,0.0875626164098287,0,0,16.27823240589198,44.61874431787271,PRKN
928,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0585642627035488,0.0876930844670941,0,0,18.00995475113122,51.10559906499446,NRG1
929,GO_Biological_Process_2017b,"regulation of gene expression, epigenetic (GO:0040029)",1/86,0.0585642627035488,0.0876930844670941,0,0,18.00995475113122,51.10559906499446,HDAC4
930,GO_Biological_Process_2017b,neuron development (GO:0048666),1/86,0.0585642627035488,0.0876930844670941,0,0,18.00995475113122,51.10559906499446,PTPRD
235,GO_Biological_Process_2018,regulation of cell death (GO:0010941),1/96,0.0651633459609098,0.0877093137617309,0,0,16.106072874493925,43.98340031976613,PRKN
236,GO_Biological_Process_2018,positive regulation of protein metabolic process (GO:0051247),1/96,0.0651633459609098,0.0877093137617309,0,0,16.106072874493925,43.98340031976613,PRKN
931,GO_Biological_Process_2017b,negative regulation of MAPK cascade (GO:0043409),1/87,0.0592261122301625,0.0885296242046681,0,0,17.79964221824687,50.30877970707926,PRKN
237,GO_Biological_Process_2018,histone modification (GO:0016570),1/98,0.0664779974990266,0.0887300468710857,0,0,15.772402854877082,42.75715849568251,HDAC4
238,GO_Biological_Process_2018,regulation of insulin secretion (GO:0050796),1/98,0.0664779974990266,0.0887300468710857,0,0,15.772402854877082,42.75715849568251,PRKN
350,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,1/91,0.061869192229165,0.0889369638294247,0,0,17.005128205128205,47.32073015810725,NRG1
932,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0598875296892885,0.0893626095189732,0,0,17.594164456233422,49.53262213559414,PTPRD
934,GO_Biological_Process_2017b,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/89,0.0605485153373022,0.0900357472433368,0,0,17.393356643356643,48.77636968918565,HDAC4
933,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0605485153373022,0.0900357472433368,0,0,17.393356643356643,48.77636968918565,PTPRD
239,GO_Biological_Process_2018,cellular response to metal ion (GO:0071248),1/100,0.0677909321684321,0.0901054473405409,0,0,15.452214452214452,41.58695944336839,PRKN
240,GO_Biological_Process_2018,regulation of protein ubiquitination (GO:0031396),1/101,0.0684467563281354,0.0902252697052695,0,0,15.296923076923076,41.02174509036264,PRKN
241,GO_Biological_Process_2018,metal ion transport (GO:0030001),1/101,0.0684467563281354,0.0902252697052695,0,0,15.296923076923076,41.02174509036264,KCND3
936,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0612090694238439,0.0907035951047635,0,0,17.197061365600693,48.03930144720859,NRG1
935,GO_Biological_Process_2017b,cellular response to interleukin-1 (GO:0071347),1/90,0.0612090694238439,0.0907035951047635,0,0,17.197061365600693,48.03930144720859,HDAC4
351,WikiPathways_2019_Human,Neural Crest Differentiation WP2064,1/101,0.0684467563281354,0.0908062630881243,0,0,15.296923076923076,41.02174509036264,HDAC4
352,WikiPathways_2019_Human,Senescence and Autophagy in Cancer WP615,1/105,0.0710657711124451,0.0908062630881243,0,0,14.705621301775148,38.88386087471356,ATG16L1
973,GO_Biological_Process_2017b,negative regulation of tRNA processing (GO:2000236),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
972,GO_Biological_Process_2017b,interleukin-13-mediated signaling pathway (GO:0035772),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
966,GO_Biological_Process_2017b,interleukin-8-mediated signaling pathway (GO:0038112),1/96,0.0651633459609098,0.0911152106296562,0,0,16.106072874493925,43.98340031976613,LIFR
970,GO_Biological_Process_2017b,granulocyte colony-stimulating factor signaling pathway (GO:0038158),1/97,0.0658208864689768,0.0911152106296562,0,0,15.9375,43.36303795043664,LIFR
965,GO_Biological_Process_2017b,interleukin-12-mediated signaling pathway (GO:0035722),1/96,0.0651633459609098,0.0911152106296562,0,0,16.106072874493925,43.98340031976613,LIFR
968,GO_Biological_Process_2017b,oncostatin-M-mediated signaling pathway (GO:0038165),1/97,0.0658208864689768,0.0911152106296562,0,0,15.9375,43.36303795043664,LIFR
967,GO_Biological_Process_2017b,ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),1/97,0.0658208864689768,0.0911152106296562,0,0,15.9375,43.36303795043664,LIFR
971,GO_Biological_Process_2017b,prolactin signaling pathway (GO:0038161),1/97,0.0658208864689768,0.0911152106296562,0,0,15.9375,43.36303795043664,LIFR
969,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.0658208864689768,0.0911152106296562,0,0,15.9375,43.36303795043664,PTPRD
941,GO_Biological_Process_2017b,interleukin-11-mediated signaling pathway (GO:0038154),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
974,GO_Biological_Process_2017b,adiponectin-activated signaling pathway (GO:0033211),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
975,GO_Biological_Process_2017b,negative regulation of snoRNA processing (GO:1902797),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
976,GO_Biological_Process_2017b,negative regulation of protein maturation (GO:1903318),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
977,GO_Biological_Process_2017b,negative regulation of production of siRNA involved in RNA interference (GO:1903704),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
978,GO_Biological_Process_2017b,negative regulation of histone gene expression (GO:0036208),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
979,GO_Biological_Process_2017b,macrophage colony-stimulating factor signaling pathway (GO:0038145),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
980,GO_Biological_Process_2017b,erythropoietin-mediated signaling pathway (GO:0038162),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
981,GO_Biological_Process_2017b,interleukin-18-mediated signaling pathway (GO:0035655),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
982,GO_Biological_Process_2017b,interleukin-15-mediated signaling pathway (GO:0035723),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,LIFR
964,GO_Biological_Process_2017b,preganglionic parasympathetic fiber development (GO:0021783),1/96,0.0651633459609098,0.0911152106296562,0,0,16.106072874493925,43.98340031976613,PRKN
963,GO_Biological_Process_2017b,interleukin-2-mediated signaling pathway (GO:0038110),1/96,0.0651633459609098,0.0911152106296562,0,0,16.106072874493925,43.98340031976613,LIFR
956,GO_Biological_Process_2017b,positive regulation of androgen receptor activity (GO:2000825),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,HDAC4
961,GO_Biological_Process_2017b,interleukin-17A-mediated signaling pathway (GO:0038173),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
940,GO_Biological_Process_2017b,positive regulation of hh target transcription factor activity (GO:0007228),1/92,0.062528884006114,0.0911152106296562,0,0,16.817413355874894,46.620000334774936,HDAC4
939,GO_Biological_Process_2017b,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/92,0.062528884006114,0.0911152106296562,0,0,16.817413355874894,46.620000334774936,PRKN
938,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.062528884006114,0.0911152106296562,0,0,16.817413355874894,46.620000334774936,PTPRD
937,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.061869192229165,0.0911152106296562,0,0,17.005128205128205,47.32073015810725,NRG1
943,GO_Biological_Process_2017b,interleukin-35-mediated signaling pathway (GO:0070757),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
944,GO_Biological_Process_2017b,interleukin-27-mediated signaling pathway (GO:0070106),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
945,GO_Biological_Process_2017b,interleukin-33-mediated signaling pathway (GO:0038172),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
946,GO_Biological_Process_2017b,interleukin-17-mediated signaling pathway (GO:0097400),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
947,GO_Biological_Process_2017b,granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
948,GO_Biological_Process_2017b,interleukin-32-mediated signaling pathway (GO:0097399),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
983,GO_Biological_Process_2017b,suppression by virus of host gene expression (GO:0039657),1/98,0.0664779974990266,0.0911152106296562,0,0,15.772402854877082,42.75715849568251,PRKN
949,GO_Biological_Process_2017b,ventral cord development (GO:0007419),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,PRKN
950,GO_Biological_Process_2017b,macrophage migration inhibitory factor signaling pathway (GO:0035691),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
951,GO_Biological_Process_2017b,interleukin-7-mediated signaling pathway (GO:0038111),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
952,GO_Biological_Process_2017b,type III interferon signaling pathway (GO:0038196),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
953,GO_Biological_Process_2017b,interleukin-3-mediated signaling pathway (GO:0038156),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
954,GO_Biological_Process_2017b,central nervous system maturation (GO:0021626),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,PRKN
960,GO_Biological_Process_2017b,interleukin-9-mediated signaling pathway (GO:0038113),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
955,GO_Biological_Process_2017b,larval central nervous system remodeling (GO:0035193),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,PRKN
942,GO_Biological_Process_2017b,interleukin-21-mediated signaling pathway (GO:0038114),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
957,GO_Biological_Process_2017b,interleukin-5-mediated signaling pathway (GO:0038043),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
962,GO_Biological_Process_2017b,interleukin-34-mediated signaling pathway (GO:0061514),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
958,GO_Biological_Process_2017b,interleukin-23-mediated signaling pathway (GO:0038155),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,LIFR
959,GO_Biological_Process_2017b,central nervous system segmentation (GO:0035283),1/95,0.0645053757251089,0.0911152106296562,0,0,16.27823240589198,44.61874431787271,PRKN
986,GO_Biological_Process_2017b,positive regulation of thyroid hormone receptor activity (GO:1904169),1/99,0.0671346793118268,0.0915763988069116,0,0,15.610675039246468,42.165284659663705,HDAC4
985,GO_Biological_Process_2017b,negative regulation of rhodopsin gene expression (GO:0045871),1/99,0.0671346793118268,0.0915763988069116,0,0,15.610675039246468,42.165284659663705,PRKN
984,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0671346793118268,0.0915763988069116,0,0,15.610675039246468,42.165284659663705,NRG1
243,GO_Biological_Process_2018,monovalent inorganic cation transport (GO:0015672),1/104,0.0704116591696319,0.0920545871930843,0,0,14.849141150112024,39.400657913218666,KCND3
242,GO_Biological_Process_2018,regulation of cellular response to stress (GO:0080135),1/104,0.0704116591696319,0.0920545871930843,0,0,14.849141150112024,39.400657913218666,PRKN
987,GO_Biological_Process_2017b,protein lipidation involved in autophagosome assembly (GO:0061739),1/100,0.0677909321684321,0.0923247933341503,0,0,15.452214452214452,41.58695944336839,ATG16L1
989,GO_Biological_Process_2017b,negative regulation of rRNA processing (GO:2000233),1/101,0.0684467563281354,0.0929229698252219,0,0,15.296923076923076,41.02174509036264,PRKN
988,GO_Biological_Process_2017b,leptin-mediated signaling pathway (GO:0033210),1/101,0.0684467563281354,0.0929229698252219,0,0,15.296923076923076,41.02174509036264,LIFR
244,GO_Biological_Process_2018,response to endoplasmic reticulum stress (GO:0034976),1/106,0.0717194556475595,0.0930020583397214,0,0,14.564835164835165,38.37824191326997,PRKN
245,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),1/106,0.0717194556475595,0.0930020583397214,0,0,14.564835164835165,38.37824191326997,PTPRD
992,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.0697571195660954,0.0942545017129289,0,0,14.995475113122172,39.92898828462372,PRKN
991,GO_Biological_Process_2017b,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/103,0.0697571195660954,0.0942545017129289,0,0,14.995475113122172,39.92898828462372,PRKN
990,GO_Biological_Process_2017b,positive regulation of CREB transcription factor activity (GO:0032793),1/103,0.0697571195660954,0.0942545017129289,0,0,14.995475113122172,39.92898828462372,HDAC4
995,GO_Biological_Process_2017b,spinal cord development (GO:0021510),1/104,0.0704116591696319,0.0946915416419188,0,0,14.849141150112024,39.400657913218666,PRKN
993,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.0704116591696319,0.0946915416419188,0,0,14.849141150112024,39.400657913218666,PRKN
994,GO_Biological_Process_2017b,interleukin-4-mediated signaling pathway (GO:0035771),1/104,0.0704116591696319,0.0946915416419188,0,0,14.849141150112024,39.400657913218666,LIFR
353,WikiPathways_2019_Human,ESC Pluripotency Pathways WP3931,1/116,0.0782328500656856,0.0947029237637246,0,0,13.29163879598662,33.86796814289058,LIFR
246,GO_Biological_Process_2018,regulation of Wnt signaling pathway (GO:0030111),1/109,0.0736779473595583,0.0947712306762061,0,0,14.158119658119658,36.92510869837499,PRKN
247,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.0736779473595583,0.0947712306762061,0,0,14.158119658119658,36.92510869837499,NRG1
248,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0743299248211348,0.0952258876222571,0,0,14.027522935779816,36.46092188437438,NRG1
996,GO_Biological_Process_2017b,interleukin-6-mediated signaling pathway (GO:0070102),1/105,0.0710657711124451,0.0954216457190578,0,0,14.705621301775148,38.88386087471356,LIFR
249,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.0762833015257954,0.0969496939710308,0,0,13.649725274725276,35.124854668215484,PRKN
250,GO_Biological_Process_2018,positive regulation of developmental process (GO:0051094),1/113,0.0762833015257954,0.0969496939710308,0,0,13.649725274725276,35.124854668215484,PRKN
252,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),1/115,0.0775834254712298,0.0978225799419855,0,0,13.408906882591094,34.278549183883314,GALNTL6
251,GO_Biological_Process_2018,peptidyl-lysine modification (GO:0018205),1/115,0.0775834254712298,0.0978225799419855,0,0,13.408906882591094,34.278549183883314,HDAC4
997,GO_Biological_Process_2017b,negative regulation of mRNA processing (GO:0050686),1/108,0.0730255435103509,0.0978998692685642,0,0,14.291157440690151,37.39918712739953,PRKN
253,GO_Biological_Process_2018,chromatin remodeling (GO:0006338),1/116,0.0782328500656856,0.0982530676021799,0,0,13.29163879598662,33.86796814289058,HDAC4
998,GO_Biological_Process_2017b,cytokine-mediated signaling pathway (GO:0019221),1/109,0.0736779473595583,0.0984667894618397,0,0,14.158119658119658,36.92510869837499,LIFR
999,GO_Biological_Process_2017b,mitochondrial fusion (GO:0008053),1/109,0.0736779473595583,0.0984667894618397,0,0,14.158119658119658,36.92510869837499,PRKN
254,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.0788818500649132,0.098679647728264,0,0,13.176392572944296,33.465456074891975,NRG1
1001,GO_Biological_Process_2017b,regulation of macroautophagy (GO:0016241),1/110,0.0743299248211348,0.0990296203362324,0,0,14.027522935779816,36.46092188437438,PRKN
1000,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.0743299248211348,0.0990296203362324,0,0,14.027522935779816,36.46092188437438,PRKN
354,WikiPathways_2019_Human,Adipogenesis WP236,1/130,0.0872803294828261,0.10037237890525,0,0,11.840787119856888,28.875300617691455,LIFR
1002,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777),1/112,0.0756326016545757,0.1004532077703189,0,0,13.773388773388774,35.561069658685284,PRKN
1003,GO_Biological_Process_2017b,establishment of endothelial blood-brain barrier (GO:0014045),1/112,0.0756326016545757,0.1004532077703189,0,0,13.773388773388774,35.561069658685284,PRKN
1004,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.0769335760445817,0.1020231966711764,0,0,13.528250510551397,34.697431128919675,NRG1
1005,GO_Biological_Process_2017b,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/115,0.0775834254712298,0.1027262022443136,0,0,13.408906882591094,34.278549183883314,HDAC4
255,GO_Biological_Process_2018,negative regulation of macromolecule metabolic process (GO:0010605),1/124,0.0834129832790227,0.1035359597899154,0,0,12.422138836772984,30.855987998406988,PRKN
256,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.0834129832790227,0.1035359597899154,0,0,12.422138836772984,30.855987998406988,PTPRD
257,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.0840585958440613,0.1039329150164945,0,0,12.321339950372208,30.51060905452009,PTPRD
258,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),1/127,0.0853485543584609,0.1051204202330078,0,0,12.124542124542124,29.838640846336183,NRG1
355,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.097519303853754,0.1068068566017305,0,0,10.525729442970825,24.500792340793137,NRG1
259,GO_Biological_Process_2018,generation of neurons (GO:0048699),1/130,0.0872803294828261,0.107086250403929,0,0,11.840787119856888,28.875300617691455,PTPRD
1025,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1026,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1027,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1028,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1029,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1030,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1031,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1032,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1033,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1034,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1035,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1036,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1023,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1024,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1007,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/126,0.0847037861099424,0.1099342169929257,0,0,12.222153846153846,30.171547606030725,NRG1
1022,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1021,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1020,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1018,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1017,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1016,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1015,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1014,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1013,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1012,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1011,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1010,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1009,GO_Biological_Process_2017b,negative regulation of RNA splicing (GO:0033119),1/129,0.0866368257895979,0.1099342169929257,0,0,11.93389423076923,29.190667049405032,PRKN
1008,GO_Biological_Process_2017b,positive regulation of protein autophosphorylation (GO:0031954),1/128,0.0859929008416181,0.1099342169929257,0,0,12.028467595396728,29.51173138971605,MOB1B
1006,GO_Biological_Process_2017b,protein homotrimerization (GO:0070207),1/126,0.0847037861099424,0.1099342169929257,0,0,12.222153846153846,30.171547606030725,ATG16L1
1019,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1038,GO_Biological_Process_2017b,mRNA catabolic process (GO:0006402),1/132,0.0885660740976256,0.1099342169929257,0,0,11.658837345860247,28.261096407773028,PRKN
1039,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1056,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1055,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1040,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1054,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1053,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1052,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1051,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),2/725,0.0895617921655653,0.1099342169929257,0,0,4.440525587828493,10.714217708645794,PRKN;HDAC4
1050,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/724,0.0893500482802695,0.1099342169929257,0,0,4.44690674053555,10.740140241626452,PRKN;HDAC4
1049,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),2/723,0.0891384651515546,0.1099342169929257,0,0,4.453305594082293,10.766152754909552,PRKN;HDAC4
1048,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/722,0.0889270430544957,0.1099342169929257,0,0,4.459722222222222,10.792255673990033,PRKN;HDAC4
1047,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1046,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1045,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1044,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1043,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1042,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1041,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),2/721,0.0887157822871957,0.1099342169929257,0,0,4.466156699119147,10.818449425797851,PRKN;HDAC4
1037,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),2/720,0.0885046831315596,0.1099342169929257,0,0,4.472609099350047,10.844734440677536,PRKN;HDAC4
1057,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),2/726,0.0897736964907814,0.1100369022701292,0,0,4.434162062615101,10.68838473510168,PRKN;HDAC4
1058,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),2/727,0.0899857609961011,0.1101394906343149,0,0,4.427816091954023,10.662640899855967,PRKN;HDAC4
1059,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),2/728,0.0901979853836164,0.1102419821355312,0,0,4.421487603305785,10.636985786186305,PRKN;HDAC4
1060,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),2/729,0.0904103693557273,0.1103443768239175,0,0,4.4151765245300325,10.61141897985671,PRKN;HDAC4
1061,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),2/730,0.0906229126366678,0.1104466747759389,0,0,4.408882783882784,10.585940068052231,PRKN;HDAC4
1062,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),2/731,0.0908356149324813,0.1105488760454879,0,0,4.402606310013717,10.560548641320592,PRKN;HDAC4
260,GO_Biological_Process_2018,mitochondrial transport (GO:0006839),1/135,0.0904915378896217,0.1106007685317598,0,0,11.39609644087256,27.37910958093047,PRKN
1063,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/733,0.0912614954237625,0.1109098627104649,0,0,4.390104879160967,10.510026616011483,PRKN;HDAC4
1064,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.091773081302606,0.1113738384124978,0,0,11.22737556561086,26.815870864611973,NRG1
1065,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),2/739,0.0925429234719803,0.112149475055027,0,0,4.353007688828584,10.360518313001773,PRKN;HDAC4
261,GO_Biological_Process_2018,regulation of vesicle-mediated transport (GO:0060627),1/138,0.0924132240279793,0.1125183910875016,0,0,11.14486243683324,26.54132487567407,PRKN
1066,GO_Biological_Process_2017b,chemokine-mediated signaling pathway (GO:0070098),1/139,0.0930529477800092,0.112608503801478,0,0,11.063545150501673,26.271346249500876,LIFR
262,GO_Biological_Process_2018,neuron differentiation (GO:0030182),1/139,0.0930529477800092,0.1128665032008476,0,0,11.063545150501673,26.271346249500876,PTPRD
1067,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),2/744,0.0936150849132823,0.1131292152895722,0,0,4.322551662174304,10.238239152399451,PRKN;HDAC4
263,GO_Biological_Process_2018,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/140,0.0936922528045293,0.1132114721388062,0,0,10.98339789706696,26.005828054598982,HDAC4
1068,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/141,0.0943311393483675,0.1135148913897606,0,0,10.904395604395605,25.744666591456088,PRKN
1069,GO_Biological_Process_2017b,negative regulation of protein kinase activity (GO:0006469),1/141,0.0943311393483675,0.1135148913897606,0,0,10.904395604395605,25.744666591456088,PRKN
1070,GO_Biological_Process_2017b,protein stabilization (GO:0050821),1/141,0.0943311393483675,0.1135148913897606,0,0,10.904395604395605,25.744666591456088,PRKN
264,GO_Biological_Process_2018,modification-dependent protein catabolic process (GO:0019941),1/141,0.0943311393483675,0.1135533337816197,0,0,10.904395604395605,25.744666591456088,PRKN
265,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.0949696076866661,0.1138921235039341,0,0,10.826513911620294,25.487761269858467,PTPRD
1071,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1/142,0.0949696076866661,0.1139635292239993,0,0,10.826513911620294,25.487761269858467,PRKN
1072,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072336),1/142,0.0949696076866661,0.1139635292239993,0,0,10.826513911620294,25.487761269858467,PRKN
1075,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1/143,0.0956076580490527,0.1142498197856368,0,0,10.74972914409534,25.235014503062555,PRKN
1074,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.0956076580490527,0.1142498197856368,0,0,10.74972914409534,25.235014503062555,NRG1
1073,GO_Biological_Process_2017b,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),1/143,0.0956076580490527,0.1142498197856368,0,0,10.74972914409534,25.235014503062555,PRKN
1076,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),2/756,0.0962040169961205,0.1148025682651897,0,0,4.251105216622458,9.953045329407365,PRKN;HDAC4
266,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.0962452906927208,0.1149896918763218,0,0,10.674018289402904,24.9863315899439,NRG1
1077,GO_Biological_Process_2017b,type I interferon signaling pathway (GO:0060337),1/148,0.0987916491782093,0.1175634327252477,0,0,10.381475667189951,24.030439828110733,LIFR
1078,GO_Biological_Process_2017b,positive regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085033),1/148,0.0987916491782093,0.1175634327252477,0,0,10.381475667189951,24.030439828110733,PRKN
267,GO_Biological_Process_2018,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/148,0.0987916491782093,0.1175915525665999,0,0,10.381475667189951,24.030439828110733,PRKN
268,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),2/771,0.0994708318387379,0.1179598340392468,0,0,4.164932813177287,9.612210226869053,PRKN;HDAC4
1079,GO_Biological_Process_2017b,protein homooligomerization (GO:0051260),1/150,0.100062328683337,0.1189106343633008,0,0,10.241094475993805,23.574610325457964,ATG16L1
269,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1013313443828346,0.1192793315797943,0,0,10.10443199184921,23.1326773144184,NRG1
270,GO_Biological_Process_2018,protein stabilization (GO:0050821),1/152,0.1013313443828346,0.1192793315797943,0,0,10.10443199184921,23.1326773144184,PRKN
1080,GO_Biological_Process_2017b,positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway (GO:1902844),1/151,0.1006970443915384,0.1194993970787551,0,0,10.172307692307692,23.351944532409743,PRKN
1081,GO_Biological_Process_2017b,protein targeting to mitochondrion (GO:0006626),1/152,0.1013313443828346,0.1200860407188841,0,0,10.10443199184921,23.1326773144184,PRKN
1082,GO_Biological_Process_2017b,interleukin-1-mediated signaling pathway (GO:0070498),1/157,0.1044966176709083,0.1236663420160543,0,0,9.77810650887574,22.084836982249676,LIFR
271,GO_Biological_Process_2018,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/163,0.1082812799250999,0.1265264772751168,0,0,9.413105413105413,20.92554977633388,PRKN
272,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.1082812799250999,0.1265264772751168,0,0,9.413105413105413,20.92554977633388,NRG1
1083,GO_Biological_Process_2017b,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/162,0.1076515360798509,0.1272245426398238,0,0,9.472049689440992,21.111832756245477,PRKN
1084,GO_Biological_Process_2017b,Kit signaling pathway (GO:0038109),1/163,0.1082812799250999,0.1277927622774907,0,0,9.413105413105413,20.92554977633388,LIFR
1085,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),1/164,0.1089106110774197,0.1283589344841018,0,0,9.354884379424258,20.74190985275421,PRKN
273,GO_Biological_Process_2018,mitochondrion organization (GO:0007005),1/167,0.1107961308995712,0.1289925757553402,0,0,9.184430027803522,20.206328583253025,PRKN
1086,GO_Biological_Process_2017b,negative regulation of translation (GO:0017148),1/166,0.1101680363222428,0.1296627917208289,0,0,9.24055944055944,20.3823499020957,PRKN
274,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),1/170,0.1126779454320236,0.1307064167011474,0,0,9.02002730996814,19.692718183242675,GALNTL6
1087,GO_Biological_Process_2017b,negative regulation of gene expression (GO:0010629),1/169,0.1120510852139714,0.1316983987857362,0,0,9.074175824175825,19.861559616416795,PRKN
1088,GO_Biological_Process_2017b,positive regulation of NF-kappaB import into nucleus (GO:0042346),1/170,0.1126779454320236,0.1322540043511303,0,0,9.02002730996814,19.692718183242675,PRKN
275,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.1151812793562318,0.133126188821152,0,0,8.809693196976434,19.039932238782733,PRKN
1090,GO_Biological_Process_2017b,protein homotetramerization (GO:0051289),1/173,0.1145560614295475,0.1340915425737404,0,0,8.861359570661897,19.199827642632822,ATG16L1
1089,GO_Biological_Process_2017b,membrane repolarization (GO:0086009),1/173,0.1145560614295475,0.1340915425737404,0,0,8.861359570661897,19.199827642632822,KCND3
277,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1170544743988581,0.1343179040763875,0,0,8.658216783216783,18.57287813568562,NRG1
276,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/848,0.1167429132168383,0.1343179040763875,0,0,3.7706855791962175,8.098607163626419,PRKN;HDAC4
278,GO_Biological_Process_2018,negative regulation of protein phosphorylation (GO:0001933),1/178,0.117678053994405,0.1345494595850007,0,0,8.608865710560625,18.421274429233133,PRKN
1091,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.1151812793562318,0.1346396971221348,0,0,8.809693196976434,19.039932238782733,PRKN
279,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.1207898224359765,0.1376141191324161,0,0,8.370245139475909,17.69221434111893,PTPRD
1092,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/179,0.1183012246238511,0.1380985724180466,0,0,8.560069144338808,18.27164868713807,PRKN
1093,GO_Biological_Process_2017b,neuron-neuron synaptic transmission (GO:0007270),1/184,0.1214109519607804,0.1415361369325402,0,0,8.324085750315259,17.55195237329604,DLGAP2
280,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),1/190,0.1251291806053908,0.1420505644595006,0,0,8.057387057387057,16.746542799136375,ATG16L1
1094,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1226519888064027,0.142788882491036,0,0,8.233264033264033,17.276716593711583,PTPRD
1096,GO_Biological_Process_2017b,ferredoxin metabolic process (GO:0006124),1/188,0.1238913976914566,0.1434531973269498,0,0,8.144385026737968,17.008325836994665,PRKN
1098,GO_Biological_Process_2017b,cellular protein metabolic process (GO:0044267),1/188,0.1238913976914566,0.1434531973269498,0,0,8.144385026737968,17.008325836994665,PRKN
1095,GO_Biological_Process_2017b,rhodopsin metabolic process (GO:0046154),1/188,0.1238913976914566,0.1434531973269498,0,0,8.144385026737968,17.008325836994665,PRKN
1097,GO_Biological_Process_2017b,prosthetic group metabolic process (GO:0051189),1/188,0.1238913976914566,0.1434531973269498,0,0,8.144385026737968,17.008325836994665,PRKN
1099,GO_Biological_Process_2017b,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/189,0.124510492276309,0.143975744438104,0,0,8.100654664484452,16.87662276492899,HDAC4
1100,GO_Biological_Process_2017b,protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process (GO:1902376),1/192,0.1263653395273989,0.1457277705840164,0,0,7.97221103503826,16.491140736895943,PRKN
1101,GO_Biological_Process_2017b,ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),1/192,0.1263653395273989,0.1457277705840164,0,0,7.97221103503826,16.491140736895943,PRKN
1102,GO_Biological_Process_2017b,mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671),1/193,0.1269828105818451,0.1462432905761384,0,0,7.930288461538462,16.36576446196824,PRKN
330,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.117678053994405,0.1463679834241879,0,0,8.608865710560625,18.421274429233133,ATG16L1
323,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.091773081302606,0.1463679834241879,0,0,11.22737556561086,26.815870864611973,PRKN
324,KEGG_2019_Human,Apelin signaling pathway,1/137,0.091773081302606,0.1463679834241879,0,0,11.22737556561086,26.815870864611973,HDAC4
325,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.0930529477800092,0.1463679834241879,0,0,11.063545150501673,26.271346249500876,LIFR
326,KEGG_2019_Human,Parkinson disease,1/142,0.0949696076866661,0.1463679834241879,0,0,10.826513911620294,25.487761269858467,PRKN
327,KEGG_2019_Human,Hippo signaling pathway,1/160,0.1063908092919722,0.1463679834241879,0,0,9.592162554426706,21.492545549184012,MOB1B
328,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.1076515360798509,0.1463679834241879,0,0,9.472049689440992,21.111832756245477,LIFR
329,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.109539529792404,0.1463679834241879,0,0,9.297373358348969,20.560860328803205,PRKN
321,KEGG_2019_Human,ErbB signaling pathway,1/85,0.0579019808424562,0.1463679834241879,0,0,18.225274725274726,51.92387482596371,NRG1
331,KEGG_2019_Human,Alcoholism,1/180,0.1189239865321526,0.1463679834241879,0,0,8.5118177911474,18.12396472528597,HDAC4
320,KEGG_2019_Human,Mitophagy,1/65,0.0445651519182939,0.1463679834241879,0,0,23.94471153846154,74.4872822237409,PRKN
319,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0214894793855565,0.1463679834241879,0,0,51.16923076923077,196.4996601316088,GALNTL6
322,KEGG_2019_Human,Autophagy,1/128,0.0859929008416181,0.1463679834241879,0,0,12.028467595396728,29.51173138971605,ATG16L1
1104,GO_Biological_Process_2017b,protein repair (GO:0030091),1/194,0.1275998763866666,0.1465605005887015,0,0,7.888800318852132,16.241902897594844,PRKN
1103,GO_Biological_Process_2017b,transcription factor catabolic process (GO:0036369),1/194,0.1275998763866666,0.1465605005887015,0,0,7.888800318852132,16.241902897594844,PRKN
1105,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),1/195,0.1282165371568791,0.1470719102681848,0,0,7.847739888977002,16.11953042390011,PRKN
1106,GO_Biological_Process_2017b,CAAX-box protein maturation (GO:0080120),1/196,0.128832793173092,0.1475814907109652,0,0,7.807100591715976,15.998621976033611,PRKN
1108,GO_Biological_Process_2017b,proteolysis involved in cellular protein catabolic process (GO:0051603),1/198,0.130064091842753,0.148595194142586,0,0,7.727059742288168,15.761099618273684,PRKN
1107,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome (GO:0071629),1/198,0.130064091842753,0.148595194142586,0,0,7.727059742288168,15.761099618273684,PRKN
1109,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome (GO:0071630),1/200,0.1312937743788508,0.1498006095971462,0,0,7.648627754155393,15.529145947074284,PRKN
1110,GO_Biological_Process_2017b,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/201,0.1319080101902192,0.1503015574278992,0,0,7.61,15.41520024287621,PRKN
281,GO_Biological_Process_2018,regulation of autophagy (GO:0010506),1/203,0.1331352721403634,0.1506033752226096,0,0,7.533891850723534,15.191261053858508,PRKN
332,KEGG_2019_Human,Viral carcinogenesis,1/201,0.1319080101902192,0.1507520116459648,0,0,7.61,15.41520024287621,HDAC4
282,GO_Biological_Process_2018,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/204,0.1337482987677588,0.1507622166322087,0,0,7.496400151572566,15.08122493657931,PRKN
1111,GO_Biological_Process_2017b,Notch receptor processing (GO:0007220),1/202,0.1325218426925636,0.1508007175467103,0,0,7.571756601607348,15.30257912605052,PRKN
1112,GO_Biological_Process_2017b,interferon-gamma-mediated signaling pathway (GO:0060333),1/204,0.1337482987677588,0.1519947554208438,0,0,7.496400151572566,15.08122493657931,LIFR
1113,GO_Biological_Process_2017b,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/207,0.1355849642168104,0.153878173674634,0,0,7.3861090365944735,14.758603945167462,PRKN
1114,GO_Biological_Process_2017b,inflammatory response to wounding (GO:0090594),1/211,0.1380282268564196,0.1560319086203004,0,0,7.243956043956044,14.345184945738218,HDAC4
1115,GO_Biological_Process_2017b,chronic inflammatory response (GO:0002544),1/211,0.1380282268564196,0.1560319086203004,0,0,7.243956043956044,14.345184945738218,HDAC4
1116,GO_Biological_Process_2017b,inflammatory response (GO:0006954),1/211,0.1380282268564196,0.1560319086203004,0,0,7.243956043956044,14.345184945738218,HDAC4
283,GO_Biological_Process_2018,regulation of canonical Wnt signaling pathway (GO:0060828),1/213,0.1392474519835408,0.1564082295167237,0,0,7.17489114658926,14.145317256840377,PRKN
1117,GO_Biological_Process_2017b,acute inflammatory response (GO:0002526),1/212,0.1386380397354888,0.1565150501224335,0,0,7.209259934378418,14.244695765376848,HDAC4
1119,GO_Biological_Process_2017b,positive regulation of histone gene expression (GO:0036207),1/214,0.1398564638825085,0.1568586222368527,0,0,7.140845070422535,14.047032262362464,PRKN
1120,GO_Biological_Process_2017b,protein linear polyubiquitination (GO:0097039),1/214,0.1398564638825085,0.1568586222368527,0,0,7.140845070422535,14.047032262362464,PRKN
1121,GO_Biological_Process_2017b,positive regulation of snoRNA processing (GO:1902798),1/214,0.1398564638825085,0.1568586222368527,0,0,7.140845070422535,14.047032262362464,PRKN
1122,GO_Biological_Process_2017b,positive regulation of tRNA processing (GO:2000237),1/214,0.1398564638825085,0.1568586222368527,0,0,7.140845070422535,14.047032262362464,PRKN
1118,GO_Biological_Process_2017b,protein K33-linked ubiquitination (GO:1990390),1/214,0.1398564638825085,0.1568586222368527,0,0,7.140845070422535,14.047032262362464,PRKN
1123,GO_Biological_Process_2017b,positive regulation of production of siRNA involved in RNA interference (GO:1903705),1/215,0.1404650756224245,0.1569258266719273,0,0,7.107117181883537,13.949823970578867,PRKN
1124,GO_Biological_Process_2017b,positive regulation of rhodopsin gene expression (GO:0045872),1/215,0.1404650756224245,0.1569258266719273,0,0,7.107117181883537,13.949823970578867,PRKN
1125,GO_Biological_Process_2017b,negative regulation of mRNA catabolic process (GO:1902373),1/215,0.1404650756224245,0.1569258266719273,0,0,7.107117181883537,13.949823970578867,PRKN
1126,GO_Biological_Process_2017b,negative regulation of gene silencing (GO:0060969),1/216,0.1410732874782278,0.157195948904311,0,0,7.073703041144902,13.853675899116531,PRKN
1127,GO_Biological_Process_2017b,cellular protein catabolic process (GO:0044257),1/216,0.1410732874782278,0.157195948904311,0,0,7.073703041144902,13.853675899116531,PRKN
284,GO_Biological_Process_2018,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/215,0.1404650756224245,0.1572223127142225,0,0,7.107117181883537,13.949823970578867,HDAC4
1128,GO_Biological_Process_2017b,protein K27-linked ubiquitination (GO:0044314),1/217,0.1416810996644196,0.1574642273472435,0,0,7.0405982905982905,13.758571893916644,PRKN
1129,GO_Biological_Process_2017b,protein K29-linked ubiquitination (GO:0035519),1/217,0.1416810996644196,0.1574642273472435,0,0,7.0405982905982905,13.758571893916644,PRKN
286,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.1416810996644196,0.1574782954458183,0,0,7.0405982905982905,13.758571893916644,PRKN
285,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.1416810996644196,0.1574782954458183,0,0,7.0405982905982905,13.758571893916644,ATG16L1
287,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),1/219,0.1428955260651126,0.1582766417179546,0,0,6.9752999294283695,13.57143303639385,KCND3
1130,GO_Biological_Process_2017b,protein K6-linked ubiquitination (GO:0085020),1/220,0.1435021407708835,0.15907601651346,0,0,6.943097997892519,13.479367429477724,PRKN
1131,GO_Biological_Process_2017b,positive regulation of rRNA processing (GO:2000234),1/220,0.1435021407708835,0.15907601651346,0,0,6.943097997892519,13.479367429477724,PRKN
356,WikiPathways_2019_Human,VEGFA-VEGFR2 Signaling Pathway WP3888,1/236,0.1531539190400531,0.160115460814601,0,0,6.465139116202946,12.130617177509258,HDAC4
1132,GO_Biological_Process_2017b,positive regulation of protein maturation (GO:1903319),1/222,0.1447141743438141,0.1602125955961194,0,0,6.879568395405499,13.298169201047848,PRKN
1133,GO_Biological_Process_2017b,positive regulation of mRNA processing (GO:0050685),1/224,0.1459246151019019,0.1613444842234946,0,0,6.81717833735771,13.12078540049272,PRKN
1134,GO_Biological_Process_2017b,protein ubiquitination (GO:0016567),1/226,0.1471334650429123,0.1620545738213334,0,0,6.755897435897436,12.947104391599886,PRKN
1135,GO_Biological_Process_2017b,actin ubiquitination (GO:0007014),1/226,0.1471334650429123,0.1620545738213334,0,0,6.755897435897436,12.947104391599886,PRKN
1136,GO_Biological_Process_2017b,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1/226,0.1471334650429123,0.1620545738213334,0,0,6.755897435897436,12.947104391599886,PRKN
1137,GO_Biological_Process_2017b,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/227,0.1477372940061224,0.1625110234067346,0,0,6.725663716814159,12.861618703149729,PRKN
1141,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.150750488845896,0.1649794890685954,0,0,6.578421578421579,12.44722356252843,NRG1
1140,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.150750488845896,0.1649794890685954,0,0,6.578421578421579,12.44722356252843,NRG1
1139,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.150750488845896,0.1649794890685954,0,0,6.578421578421579,12.44722356252843,NRG1
1138,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.150750488845896,0.1649794890685954,0,0,6.578421578421579,12.44722356252843,NRG1
1142,GO_Biological_Process_2017b,vacuolar protein processing (GO:0006624),1/233,0.1513519394762967,0.1652162392756521,0,0,6.54973474801061,12.366864825645834,PRKN
1143,GO_Biological_Process_2017b,mitochondrial protein processing (GO:0034982),1/233,0.1513519394762967,0.1652162392756521,0,0,6.54973474801061,12.366864825645834,PRKN
1144,GO_Biological_Process_2017b,histone ubiquitination (GO:0016574),1/235,0.1525536543333662,0.1663164363634412,0,0,6.493096646942801,12.208572982222558,PRKN
289,GO_Biological_Process_2018,regulation of signal transduction (GO:0009966),1/233,0.1513519394762967,0.1664871334239263,0,0,6.54973474801061,12.366864825645834,LIFR
288,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1513519394762967,0.1664871334239263,0,0,6.54973474801061,12.366864825645834,NRG1
1145,GO_Biological_Process_2017b,sterol regulatory element binding protein cleavage (GO:0035103),1/236,0.1531539190400531,0.1665476077773962,0,0,6.465139116202946,12.130617177509258,PRKN
1146,GO_Biological_Process_2017b,protein K11-linked ubiquitination (GO:0070979),1/236,0.1531539190400531,0.1665476077773962,0,0,6.465139116202946,12.130617177509258,PRKN
1148,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.1537537889241329,0.166753641903916,0,0,6.4374185136897,12.05343999397185,NRG1
1149,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1004,0.1539264386805379,0.166753641903916,0,0,3.157684630738523,5.908913553380438,PRKN;HDAC4
1147,GO_Biological_Process_2017b,protein monoubiquitination (GO:0006513),1/237,0.1537537889241329,0.166753641903916,0,0,6.4374185136897,12.05343999397185,PRKN
1150,GO_Biological_Process_2017b,protein K63-linked ubiquitination (GO:0070534),1/238,0.1543532642057949,0.1670051711079093,0,0,6.409931840311587,11.97703058979952,PRKN
290,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),2/1001,0.153187978185525,0.1679277149181528,0,0,3.167667667667668,5.9428280385373125,PTPRD;ASB3
291,GO_Biological_Process_2018,proteasomal protein catabolic process (GO:0010498),1/237,0.1537537889241329,0.1679707488588986,0,0,6.4374185136897,12.05343999397185,PRKN
1151,GO_Biological_Process_2017b,protein K6-linked deubiquitination (GO:0044313),1/242,0.1567472242308717,0.1681217664684516,0,0,6.302266198531759,11.678860629309971,PRKN
1153,GO_Biological_Process_2017b,protein K48-linked ubiquitination (GO:0070936),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1154,GO_Biological_Process_2017b,protein deubiquitination (GO:0016579),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1155,GO_Biological_Process_2017b,protein K48-linked deubiquitination (GO:0071108),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1157,GO_Biological_Process_2017b,protein K11-linked deubiquitination (GO:0035871),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1158,GO_Biological_Process_2017b,protein K29-linked deubiquitination (GO:0035523),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1159,GO_Biological_Process_2017b,protein K33-linked deubiquitination (GO:1990168),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1160,GO_Biological_Process_2017b,protein linear deubiquitination (GO:1990108),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1156,GO_Biological_Process_2017b,protein K27-linked deubiquitination (GO:1990167),1/243,0.1573447301563714,0.1681217664684516,0,0,6.275905912269549,11.60613414220436,PRKN
1152,GO_Biological_Process_2017b,monoubiquitinated protein deubiquitination (GO:0035520),1/242,0.1567472242308717,0.1681217664684516,0,0,6.302266198531759,11.678860629309971,PRKN
1161,GO_Biological_Process_2017b,protein K63-linked deubiquitination (GO:0070536),1/244,0.1579418429462565,0.1685498771739901,0,0,6.249762583095916,11.53411431744196,PRKN
1162,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.1585385627984369,0.1689765054423092,0,0,6.223833543505675,11.462791589955357,NRG1
1163,GO_Biological_Process_2017b,ubiquitin-dependent ERAD pathway (GO:0030433),1/247,0.1597308247192458,0.1700360392172616,0,0,6.1726078799249535,11.32219998778981,PRKN
1164,GO_Biological_Process_2017b,positive regulation of RNA splicing (GO:0033120),1/248,0.1603263672562964,0.1704585168598542,0,0,6.147306135160386,11.252912800184223,PRKN
1166,GO_Biological_Process_2017b,signal peptide processing (GO:0006465),1/250,0.1615162767103545,0.1708766527959114,0,0,6.097312326227989,11.11631104585427,PRKN
1165,GO_Biological_Process_2017b,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/249,0.1609215178436894,0.1708766527959114,0,0,6.1222084367245655,11.184286075137171,PRKN
1167,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.1615162767103545,0.1708766527959114,0,0,6.097312326227989,11.11631104585427,NRG1
1168,GO_Biological_Process_2017b,histone deubiquitination (GO:0016578),1/250,0.1615162767103545,0.1708766527959114,0,0,6.097312326227989,11.11631104585427,PRKN
1169,GO_Biological_Process_2017b,positive regulation of I-kappaB phosphorylation (GO:1903721),1/252,0.162704620190779,0.1719218769996162,0,0,6.048115231382163,10.982281753993297,PRKN
1170,GO_Biological_Process_2017b,protein autoubiquitination (GO:0051865),1/253,0.1632982053052164,0.1723368513553206,0,0,6.023809523809524,10.916210693256447,PRKN
292,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),2/1037,0.1621015475418591,0.1764859852076896,0,0,3.0516908212560385,5.552650029422287,PRKN;HDAC4
1171,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by transcription from RNA polymerase II promoter (GO:0100038),1/260,0.167442372755909,0.176493311823796,0,0,5.858924858924859,10.47057853489794,PRKN
293,GO_Biological_Process_2018,inflammatory response (GO:0006954),1/252,0.162704620190779,0.17654004707775,0,0,6.048115231382163,10.982281753993297,HDAC4
294,GO_Biological_Process_2018,protein deubiquitination (GO:0016579),1/257,0.1656686404074924,0.1791467670847122,0,0,5.928485576923077,10.658027594484167,PRKN
295,GO_Biological_Process_2018,protein modification by small protein removal (GO:0070646),1/261,0.1680328383365897,0.181089444018149,0,0,5.836094674556213,10.409234255697912,PRKN
1172,GO_Biological_Process_2017b,apoptotic mitochondrial changes (GO:0008637),1/268,0.1721552220259798,0.1812382582801112,0,0,5.6810717372515125,9.99504330153276,PRKN
1173,GO_Biological_Process_2017b,cellular protein modification process (GO:0006464),1/271,0.1739161448381884,0.1828677111166246,0,0,5.617094017094017,9.825319871419756,PRKN
1174,GO_Biological_Process_2017b,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/272,0.1745023457521934,0.1832595014141762,0,0,5.596082883905762,9.769737162215218,LIFR
1175,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.1750881603853759,0.1836499286193796,0,0,5.575226244343892,9.714640267906365,NRG1
296,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),1/268,0.1721552220259798,0.1849074606945709,0,0,5.6810717372515125,9.99504330153276,PRKN
1176,GO_Biological_Process_2017b,positive regulation of translation (GO:0045727),1/277,0.177427560792881,0.1858764922592086,0,0,5.493311036789297,9.498994231225057,PRKN
1177,GO_Biological_Process_2017b,positive regulation of gene expression (GO:0010628),1/282,0.1803431480452471,0.1887005134424659,0,0,5.394196550780181,9.239686177870396,PRKN
297,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),1/276,0.1768432889235123,0.1893053998879209,0,0,5.513566433566433,9.552205943716622,PRKN
298,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.1780114475184346,0.1899185677537814,0,0,5.473201888364343,9.446239744028276,NRG1
333,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.1873014512119106,0.1901845225149245,0,0,5.170123391966396,8.660142400134523,LIFR
334,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.1901845225149245,0.1901845225149245,0,0,5.082085699535364,8.435045137136205,HDAC4
299,GO_Biological_Process_2018,protein polyubiquitination (GO:0000209),1/283,0.1809251127499742,0.1917445547084444,0,0,5.374795417348609,9.18913763411473,PRKN
300,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.1809251127499742,0.1917445547084444,0,0,5.374795417348609,9.18913763411473,NRG1
301,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1120,0.1830444689307931,0.1933482966520629,0,0,2.812760882528325,4.776141549215091,PRKN;HDAC4
302,GO_Biological_Process_2018,chemical synaptic transmission (GO:0007268),1/289,0.184408851312815,0.1941466124382442,0,0,5.261217948717949,8.894614897847239,DLGAP2
1178,GO_Biological_Process_2017b,protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044),1/292,0.1861455563110536,0.1945345765102119,0,0,5.206185567010309,8.752776360839471,PRKN
303,GO_Biological_Process_2018,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/291,0.1855670365724471,0.194723304824377,0,0,5.224403183023873,8.799666446026235,PRKN
1179,GO_Biological_Process_2017b,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367),1/303,0.1924841384230909,0.2006699766306343,0,0,5.013754457463067,8.261371422992246,PRKN
1180,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427),1/303,0.1924841384230909,0.2006699766306343,0,0,5.013754457463067,8.261371422992246,PRKN
357,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.2016221000042087,0.2016221000042087,0,0,4.757619738751814,7.618662543148452,NRG1
1181,GO_Biological_Process_2017b,protein phosphorylation involved in cellular protein catabolic process (GO:1902002),1/310,0.196493881366796,0.2046016386076589,0,0,4.898431665421957,7.97035565776603,PRKN
1182,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/1175,0.1971790019661048,0.2050661620447491,0,0,2.6730605285592497,4.3400968801997415,PRKN;HDAC4
1183,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by transcription from RNA polymerase II promoter (GO:0100069),1/317,0.2004851294148895,0.2082521077941588,0,0,4.788218111002921,7.694739297233262,PRKN
1184,GO_Biological_Process_2017b,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/329,0.2072844667933784,0.2150545012197323,0,0,4.610225140712946,7.254941617216534,PRKN
1185,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/344,0.2157081320821701,0.2235236441141327,0,0,4.405247813411079,6.756896960319634,PRKN
304,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),1/341,0.2140300779756266,0.2238544094236882,0,0,4.444796380090498,6.852270213391879,PRKN
1186,GO_Biological_Process_2017b,translation (GO:0006412),1/348,0.2179403628390706,0.2255643321060586,0,0,4.353580137441809,6.63282657127839,PRKN
1188,GO_Biological_Process_2017b,C-terminal protein amino acid modification (GO:0018410),1/355,0.2218325767498778,0.2287648447733115,0,0,4.265971316818774,6.423837572148413,ASB3
1189,GO_Biological_Process_2017b,CAAX-box protein modification (GO:0071587),1/355,0.2218325767498778,0.2287648447733115,0,0,4.265971316818774,6.423837572148413,ASB3
1187,GO_Biological_Process_2017b,N-terminal protein amino acid propionylation (GO:0061606),1/355,0.2218325767498778,0.2287648447733115,0,0,4.265971316818774,6.423837572148413,ASB3
305,GO_Biological_Process_2018,post-translational protein modification (GO:0043687),1/357,0.2229413295087138,0.2324126931806526,0,0,4.241573033707865,6.365950629641142,ASB3
1190,GO_Biological_Process_2017b,post-translational protein acetylation (GO:0034421),1/368,0.2290132935131917,0.2358864415778133,0,0,4.112135820582688,6.06118632892711,ASB3
306,GO_Biological_Process_2018,organelle assembly (GO:0070925),1/376,0.2334015624966441,0.2425247506072621,0,0,4.022769230769231,5.853108572443737,ATG16L1
1191,GO_Biological_Process_2017b,protein polyubiquitination (GO:0000209),1/381,0.2361324409407573,0.2429276190973258,0,0,3.968825910931174,5.728454254459795,PRKN
1192,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.2393975703766961,0.2459917549499464,0,0,3.905938620964528,5.584045603897804,PTPRD
1193,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process (GO:0043524),1/399,0.2458889854721736,0.2523597482477572,0,0,3.7858523386161576,5.31107806699423,PRKN
307,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.2442709723117814,0.2529949356086308,0,0,3.8151898734177214,5.377422864122798,NRG1
308,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),1/398,0.2453500055050913,0.2532901351330878,0,0,3.795582251501647,5.333056833585132,PRKN
1194,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1/413,0.2533972701118748,0.259754907713248,0,0,3.6545929798356975,5.017013490250188,PRKN
1195,GO_Biological_Process_2017b,post-translational protein modification (GO:0043687),1/429,0.2618931413496548,0.268143574317427,0,0,3.51509705248023,4.709592818982871,ASB3
309,GO_Biological_Process_2018,cellular response to cytokine stimulus (GO:0071345),1/456,0.2760266492318054,0.2840403261449868,0,0,3.301944209636517,4.250453646178265,LIFR
310,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),2/1478,0.277284777347674,0.2844175047392541,0,0,2.0901084010840107,2.6810034149974062,PRKN;HDAC4
1198,GO_Biological_Process_2017b,"positive regulation of mating-type specific transcription, DNA-templated (GO:0045895)",1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1199,GO_Biological_Process_2017b,positive regulation of antisense RNA transcription (GO:0060196),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1200,GO_Biological_Process_2017b,positive regulation of transcription by pheromones (GO:0009371),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1201,GO_Biological_Process_2017b,positive regulation of chromatin-mediated maintenance of transcription (GO:1904501),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1202,GO_Biological_Process_2017b,positive regulation of transcription during mitotic cell cycle (GO:0045897),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1203,GO_Biological_Process_2017b,nitrogen catabolite activation of transcription (GO:0090294),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1204,GO_Biological_Process_2017b,positive regulation of transcription from mitochondrial promoter (GO:1903109),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1196,GO_Biological_Process_2017b,positive regulation of transcription from a mobile element promoter (GO:0061435),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1197,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase V promoter (GO:1904281),1/469,0.2827416640808824,0.2864136337442705,0,0,3.2080867850098618,4.0525246690995225,HDAC4
1205,GO_Biological_Process_2017b,carbon catabolite activation of transcription (GO:0045991),1/470,0.2832558006951458,0.2865960813637206,0,0,3.2010824995899623,4.037861150987325,HDAC4
1206,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, termination (GO:0060566)",1/472,0.284283047448757,0.2872966486584612,0,0,3.1871631553160213,4.008765662534434,HDAC4
1207,GO_Biological_Process_2017b,positive regulation of transcription involved in exit from mitosis (GO:0007072),1/481,0.28888876236948,0.2916077154270751,0,0,3.1259615384615387,3.881548862420641,HDAC4
1208,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/482,0.289398806099152,0.2917792898155963,0,0,3.11930273468735,3.867778147673038,HDAC4
1209,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),1/485,0.2909268996869506,0.2929756806706615,0,0,3.099491417673236,3.826890128218145,HDAC4
1210,GO_Biological_Process_2017b,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),1/487,0.291943932972439,0.2936552104224533,0,0,3.08641975308642,3.799979955304215,HDAC4
1211,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/488,0.2924519414995407,0.2938217398203817,0,0,3.079924182593587,3.786627965311164,HDAC4
1212,GO_Biological_Process_2017b,positive regulation of transcription by transcription factor localization (GO:0061586),1/490,0.2934669433692941,0.2944966519425196,0,0,3.067012741859368,3.7601277951965417,HDAC4
1213,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/493,0.2949869113114428,0.2956761330668433,0,0,3.047842401500938,3.720880042130186,HDAC4
312,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.2909268996869506,0.2965037731633778,0,0,3.099491417673236,3.826890128218145,PRKN
311,GO_Biological_Process_2018,cellular protein metabolic process (GO:0044267),1/484,0.290417874511898,0.2965037731633778,0,0,3.10606784519828,3.84044927720584,PRKN
1214,GO_Biological_Process_2017b,negative regulation of chromatin silencing (GO:0031936),1/509,0.3030422550875969,0.3033958633199045,0,0,2.9494245911568746,3.521267960158797,HDAC4
313,GO_Biological_Process_2018,positive regulation of nucleic acid-templated transcription (GO:1903508),1/502,0.2995286166998742,0.3042981806600633,0,0,2.991708889912483,3.606640644288343,HDAC4
314,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),1/506,0.3015384188891201,0.305367478176601,0,0,2.9674028941355672,3.5574942392018785,PRKN
315,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",2/1598,0.3094328751437878,0.3123705290217352,0,0,1.9204260651629077,2.2526868370475004,HDAC4;NRG1
316,GO_Biological_Process_2018,negative regulation of cellular process (GO:0048523),1/534,0.3154578087779517,0.3174480788648789,0,0,2.8074758262375523,3.2390700228812856,PRKN
1215,GO_Biological_Process_2017b,chromatin-mediated maintenance of transcription (GO:0048096),1/554,0.3252420432874212,0.3252420432874212,0,0,2.703157601891779,3.0361477612661285,HDAC4
317,GO_Biological_Process_2018,cytokine-mediated signaling pathway (GO:0019221),1/633,0.362634201056534,0.3637745601793534,0,0,2.3556475170399223,2.389476178090609,LIFR
318,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.4415789221359919,0.4415789221359919,0,0,1.811755811755812,1.48092651157323,PRKN
